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Summary 
 
Synthesis of ribosomal RNA by RNA polymerase (Pol) I is the first step in 
ribosome biogenesis and a regulatory switch in eukaryotic cell growth. In this 
thesis a reproducible large-scale purification protocol for Pol I from S. cerevisiae 
could be developed. Crystals were obtained, diffraction to < 4 Å could be 
recorded, however, the enormously complex non-crystallographic symmetry 
impeded structure solution. 
Switching to cryo-electron microscopy, the structure of the complete 14-subunit 
enzyme could be solved to 12 Å resolution, a homology model for the core 
enzyme could be generated, and the crystal structure of the subcomplex 
A14/43 could be solved. In the resulting hybrid structure of Pol I, A14/43, the 
clamp, and the dock domain contribute to a unique surface interacting with 
promoter-specific initiation factors. The Pol I-specific subunits A49 and A34.5 
form a heterodimer near the enzyme funnel that acts as a built-in elongation 
factor, and is related to the Pol II-associated factor TFIIF. In contrast to Pol II, 
Pol I has a strong intrinsic 3’-RNA cleavage activity, which requires the C-
terminal domain of subunit A12.2, and apparently enables rRNA proofreading 
and 3’-end trimming.  
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I.1 | Eukaryotic RNA polymerases 
 
Transcription of genetic information requires specific multisubunit enzymes, 
RNA polymerases, that translate the information stored in DNA very reliably into 
RNA. In bacteria and archaea just a single RNA polymerase is synthesizing all 
cellular RNA. By contrast, there are 3 different types of enzymes catalyzing 
DNA-dependent RNA synthesis in eukaryotes (Table 1 for details): 
RNA polymerase III transcribes various short non-translated RNA molecules, 
including the 5S ribosomal RNA (rRNA), transfer RNA (tRNA), 7SL RNA (an 
essential component of the signal-recognition particle) and RNA molecules 
required for post-translational processing of rRNA, mRNA and tRNA. In 
addition, Pol III synthesizes short interspersed nuclear elements (SINES), 
including for example over 1 million Alu genes in humans (Geiduschek and 
Kassavetis, 2001). 
RNA polymerase II transcribes all protein-coding genes (Cramer, 2004), as well 
as many small RNA molecules that regulate transcription of other genes 
through various mechanisms (Dye et al., 2006). 
RNA polymerase I (Pol I) is solely dedicated to transcribing ribosomal RNA 
(rRNA). In yeast rRNA is transcribed in form of a 35S precursor-rRNA, which 
gets subsequently processed into 25S, 5.8S and 18S rRNA and assembles into 
native ribosomes.  
Throughout this thesis Saccharomyces cerevisiae serves as model organism. 
Most phenomena will be discussed using S. cerevisiae as model system, but 
cross-references to other organisms are given, wherever enough knowledge of 
that system has been acquired.  
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Table 1 | Subunit composition of eukaryotic RNA polymerases 
 
Polymerase 
part 
Pol I subunit MW (kDa) 
Corresponding 
Pol II subunit 
Corresponding 
Pol III subunit 
Subunit type 
A190 186.4 Rpb1 C160 homolog 
A135 135.7 Rpb2 C128 homolog 
AC40 37.7 Rpb3 AC40 homolog 
AC19 16.2 Rpb11 AC19 homolog 
A12.2 13.7 Rpb9 C11 homolog 
Rpb5 (ABC27) 25.1 Rpb5 Rpb5 common 
Rpb6 (ABC23) 17.9 Rpb6 Rpb6 common 
Rpb8 (ABC14.5) 16.5 Rpb8 Rpb8 common 
Rpb10 (ABC10β) 8.3 Rpb10 Rpb10 common 
Core 
Rpb12 (ABC10α) 7.7 Rpb12 Rpb12 common 
A14 14.6 Rpb4 C17 counterpart Subcomplex 
A14/43 A43 36.2 Rpb7 C25 counterpart 
A49 46.7 C37 (?) 
Pol I/III 
specific Subcomplex 
A49/34.5 
A34.5 26.9 
- 
C53 (?) 
Pol I/III 
specific 
C82 
Pol III 
specific 
C34 
Pol III 
specific 
Subcomplex 
C82/34/31 
- - - 
C31 
Pol III 
specific 
Total 14 subunits 589.6 12 subunits 17 subunits - 
 
 
I.2 | General importance of rDNA transcription 
 
The ribosome, one of the most ancient and complex molecular machines in the 
cell, is composed of ~ 60% RNA and ~ 40% protein. The large subunit of the 
eukaryotic 80S ribosome, the 60S subunit, is composed of 3 RNA species, the 
25S rRNA, the 5.8S rRNA and the 5S rRNA, and 42 proteins. The small 40S 
subunit contains just a single RNA species (18S rRNA) and 32 proteins.  
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All ribosomal RNA has to be synthesized by RNA polymerase I. Given the 
overwhelming emphasis paid to transcription of protein coding genes, it is 
astonishing that every cell has to provide 10 ribosomes per synthesized mRNA 
molecule. Ribosome biogenesis consumes an enormous fraction of the energy 
of a cell and needs therefore to be tightly regulated, mainly at the level of rDNA 
transcription (Grummt, 2003; Moss et al., 2007). As a consequence of this 
central importance, Pol I transcription accounts for up to 60% of all nuclear 
transcription, resulting in up 80% of total RNA in a cell (Warner, 1999).  
Although highly enlarged nucleoli had been associated with cancer since 1896 
(Pianese, 1896), deregulated Pol I and Pol III have just recently been implicated 
to have major impact on the growth potential of tumors (White, 2005). There is a 
growing body of evidence that Pol I transcription is one of the key regulators of 
cell growth and proliferation and a major signaling target after nutrient 
deprivation. 
 
 
I.3 | Structural organization of rDNA loci 
 
The nucleolus is the cellular compartment where rDNA transcription takes place 
(Fig. 1). In fact, rDNA transcription is the basis for the formation of a nucleolus, 
which is not separated from the nucleoplasm by a membrane. It turns out that 
the nucleolus hosts not only rDNA transcription, pre-rRNA processing and 
modification, but is also needed for snRNA- and tRNA-maturation and the 
biogenesis of ribonucleic particles in general (Thiry and Lafontaine, 2005). 
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Figure 1 | Nucleolar organization in human and S. cerevisiae cells. (a,b) Electron 
micrographs of a human nucleolus and a yeast nucleus, respectively; Bars, 0.25 µm. (Note that 
a human nucleolus is as large as a yeast nucleus). (c,d) ‘Blueprint’ cartoons of panels (a) and 
(b), respectively. Key: F, fibrillar component; FC, fibrillar center; DFC, dense fibrillar component; 
G or GC, granular component; Ni, nucleolar interstices; Ch, condensed chromatin. In panel (d), 
the yeast nuclear envelope is outlined in light grey (Thiry and Lafontaine, 2005). 
 
In eukaryotes, rDNA genes are tandemly repeated at one or a few loci. Each 
repeat is separated from the subsequent one by a intergenic spacer (IGS) 
region that is important for rDNA silencing (Chapter I.4). S. cerevisiae 
possesses ~ 150 copies of the rRNA gene coding for a 35S precursor rRNA on 
chromosome XII (Fig. 2). Each repeat contains important sequence elements 
such as the rDNA promoter, enhancer, the spacer promoter, an origin of 
replication and a replication fork barrier, that prevents Pol I from colliding with 
replication forks during S phase (Brewer et al., 1992). Among eukaryotes, 
S. cerevisiae is unique in that the gene for the 5S rRNA, transcribed by Pol III, 
is part of the rDNA repeats. Eukaryotic rDNA promoter sequences have 
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diverged significantly, which makes rDNA transcription specific to closely 
related species. rDNA promoter sequences are not recognized across species 
barriers (Heix and Grummt, 1995).  
Very interestingly, neither tandemly arranged rDNA repeats nor Pol I are 
absolutely required for cell viability. In a yeast strain lacking the essential Pol I 
subunit A135, rRNA can be synthesized by Pol II from a multicopy plasmid 
carrying the 35S rDNA under control of a GAL7 promoter (Nogi et al., 1991). 
 
 
 
Figure 2 | Structure of the yeast rDNA locus. Figure was prepared based on Nomura, Cold 
Spring Harb Symp Quant Biol 2001 and Granneman & Baserga, Curr Opin Cell Biol 2005. 
 
 
I.4 | Epigenetics 
 
Each of the rDNA repeat loci (one in S. cerevisiae, five in humans and mouse) 
is capable of forming a nucleolus when rRNA genes are being transcribed and 
is therefore also referred to as nucleolar organizer or NOR (Nomura, 2001). 
However, even in exponentially growing cells only half of the rDNA repeats are 
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active, excluding the obvious possibility of transcription regulation via the 
number of active genes (French et al., 2003). 
Epigenetic marks characterizing heterochromatic and euchromatic rDNA are 
very similar to protein-coding genes: DNA hypomethylation, acetylation of 
histone H4 and dimethylation of histone H3 at lysine 4 (H3K4me2) correlate 
with an ’open’ or active chromatin state, whereas CpG methylation, histone H4 
hypoacetylation and methylation of H3K9 correlate with transcriptional 
repression (Earley et al., 2006; Lawrence et al., 2004).  
Silencing of rDNA apparently requires transcription of the IGS from the spacer 
promoter (Mayer et al., 2006). The generated non-coding RNA is processed 
and incorporated into the nucleolar remodeling complex (NoRC) (Grummt, 
2007; Santoro et al., 2002). This complex associates with rDNA in TTF-I 
dependent manner (Langst et al., 1997) and leads to the recruitment of 
chromatin modifiers that establish heterochromatin. CSB (Cockayne Syndrome 
protein B), a SWI/SNF2-like DNA-dependent ATPase, and WSTF (William 
syndrome transcription factor) seem to be good candidates for establishing 
active rDNA (Bradsher et al., 2002). Perturbation of this epigenetic balance is 
associated with alterations in rRNA synthesis and genomic instability, ultimately 
leading to cell transformation and malignant growth. The most likely benefit 
from limiting the number of active rDNA repeats seems to be reduced DNA 
damage and repressed homologous recombination (Grummt, 2007). 
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Figure 3 | Miller Spread of a single rDNA repeat in yeast. Cells were heat-shocked to slow 
down rRNA processing and to keep transcripts long and well defined. The horizontal linear 
molecule is rDNA, the branches are rRNA molecules currently being transcribed. Image 
courtesy of Sarah French and Ann Beyer, University of Virginia Health System. 
 
 
I.5 | The RNA polymerase I transcription cycle 
 
In vertebrates and yeasts, the rDNA promoter is a sequence of 140-160 bp, 
containing two functional elements, a core promoter sequence and an upstream 
control element (UE). The spacing of these two elements is important in vivo, 
but in vitro the core element is sufficient for transcription initiation. 
Formation of a Pol I pre-initiation complex requires the TATA box-binding 
protein (TBP) and a group of Pol I specific TAFs (TATA-box associated factors), 
forming one or two complexes recognizing the promoter. 
In human and mouse, pre-initiation complex formation requires initial 
recruitment of SL1 (selectivity factor 1) or TIF-IB, respectively (Bell et al., 1988). 
UBF (upstream binding factor) has been implicated in the enhancement of Pol I 
transcription via formation of a putative enhancesome (Bazett-Jones et al., 
1994). 
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In yeast, there are two factors required for complex formation (Fig. 4) (Aprikian 
et al., 2001; Nomura, 2001): After establishment of the UAF (upstream 
activating factor) – UE complex, TBP is either already present or recruited along 
with the core factor. Efficient transcription requires the UAF complex, however, 
for low-level transcription neither the UAF and UE nor TBP are needed in vitro 
(Keener et al., 1998).  
Initiation of transcription in yeast and mammals requires Rrn3 or TIF-IA, 
respectively. Dependent on the phosphorylation status of Pol I, Rrn3 associates 
with a small sub-population of Pol I (Fath et al., 2001), rendering the enzyme 
initiation-competent. In mammals this regulation is complicated by TIF-IA also 
being regulated by phosphorylation (Zhao et al., 2003a). The Pol I system 
apparently lacks abortive transcription prior to promoter escape (Stefanovsky et 
al., 2006a), but there is kinetic evidence for a rate-limiting post-initiation step 
(Panov et al., 2006). 
Once Pol I makes the transition from initiation to elongation it transcribes the 
35S-precursor with a speed of ~ 5.6 kb/min (Dundr et al., 2002), which 
compares well to Pol II (Darzacq et al., 2007). Whereas actively transcribing Pol 
II molecules are on average 4 kb apart, Pol I is tightly packed on rDNA with one 
polymerase every 70 bp (Fig. 3). Pausing seems to be a Pol II specific feature, 
since pausing of so densely packed Pol I molecules would result in catastrophic 
stalling (Darzacq et al., 2007). 
Transcription termination sites are located at the 3’ end of the transcribed 
region, between the spacer and rDNA promoter. TTF-I bends the T-rich 
termination site, forces Pol I to pause and cooperates with PTRF (Pol I and 
transcript release factor) to dissociate Pol I from rDNA (Jansa and Grummt, 
1999; Russell and Zomerdijk, 2005). 
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Figure 4 | The pre-initiation complex in S. cerevisiae. Figure was prepared based on      
Moss et al., Cell.Mol.Life Sci. 2007 and Grummt, Genes & Dev 2003. As Pol I possesses up to 
15 different phosphorylation sites, the P-circle just indicates the general dependence of the     
Pol I-Rrn3 interaction on phosphorylation. 
 
 
I.6 | In vivo regulation of rDNA transcription 
 
Without new ribosomes, a cell cannot make protein and hence cannot grow and 
proliferate. In bacteria, r-protein expression is surveyed by an autoregulatory 
loop, in which free r-proteins negatively regulate their own synthesis. Thus, 
bacterial ribosome biosynthesis appears to be regulated mainly at the rRNA 
synthesis level (Gourse et al., 1986). In eukaryotes, both r-protein and rDNA 
synthesis are regulated in more sophisticated and interrelated ways, although 
also eukaryotic r-protein levels clearly depend on the level of rRNA synthesis 
(Laferte et al., 2006). Some of the eukaryotic regulation mechanisms rely on 
detection of intact 60S subunits (Zhao et al., 2003b). Blocking nuclear export of 
60S subunits leads to a coordinated shutdown of rRNA synthesis and r-protein 
expression. Strangely, this seems not to be the case for the 40S subunit. 
Apart from epigenetic mechanisms (Chapter I.3) almost any perturbation that 
slows down cell growth or interferes with protein synthesis decreases rDNA 
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transcription. Pol I transcription initiation seems to be regulated mainly via 
alterations in the phosphorylation pattern of Rrn3. In mouse, the target of 
rapamycin (mTOR) nutrient-sensing pathway (Proud, 2002) and the Jun          
N-terminal kinase pathway (JNK) regulate TIF-IA phosphorylation (Mayer et al., 
2005; Mayer et al., 2004). The Raf-MEK-ERK kinase pathway (Zhao et al., 
2003a) modulates phosphorylation of TIF-IA in mammals, thereby effecting 
formation of the TIF-IA-Pol I complex.  
As growth factor and MAP kinase activation of rRNA synthesis does not 
increase the absolute number of transcribing Pol I complexes (Stefanovsky et 
al., 2006a), Pol I elongation has to be regulated as well. Phosphorylation of 
UBF seems to be the main tool for controlling elongation. ERK phosphorylates 
the two N-terminal HMG1 boxes of UBF (Stefanovsky et al., 2001), thereby 
altering the DNA-bending capacity of UBF. This leads to remodeling of the 
hypothetical enhanceosome, which facilitates transcription elongation 
(Stefanovsky et al., 2006b). 
 
 
I.7 | Making ribosomes 
 
The structure and function of the mature cytoplasmic ribosome is well known 
(Ban et al., 2000; Schuwirth et al., 2005). However, our knowledge about the 
pathway resulting in a fully functional ribosome is still very limited (Fatica and 
Tollervey, 2002; Tschochner and Hurt, 2003). The 18S synthesis pathway, 
involving four successive endonuclease cleavages, seems to be distinct from 
25S/5.8S synthesis, which is much more complex and requires endonuclease 
cleavages followed by exonuclease digestion. Most RNA processing cleavage 
sites are used in a well-maintained order, suggesting that many proteins 
involved in the pathway function in assuring this specific order. The 18S rRNA 
probably folds into a structure close to the mature form already co-
transcriptionally and assembles with its respective r-proteins already on the 35S 
precursor rRNA. The main portion of 60S r-proteins seems to assemble with 
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RNA after the 90S pre-ribosome is processed into 66S and 43S pre-ribosomes. 
Transport into the nucleoplasm and quality control of ribosomal subunits 
involves, amongst many other factors, differential heterodimeric Noc complexes 
(nucleolar complex associated proteins) (Milkereit et al., 2001). Export of 
ribosomal subunits into the cytoplasm uses the classical pathway through the 
nuclear pore complex involving nucleoporins, karyopherins and the Ran GTP-
GDP cycle (Moy and Silver, 1999). 
 
 
 
Figure 5 | Ribosome biogenesis in S. cerevisiae. Figure was prepared based on Tschochner 
& Hurt, Trends Cell Biol 2003. Figure greatly simplifies the situation to show the basic principle. 
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I.8 | Structural studies on eukaryotic RNA polymerases 
 
To date most progress in structural studies was achieved for RNA polymerase 
II, culminating in the atomic structure of the 10-subunit core enzyme (Cramer et 
al., 2001) and the complete 12-subunit enzyme structure (Armache et al., 
2005). Based on these groundbreaking structures functional DNA-RNA hybrid 
complexes could be obtained, shedding light onto the transcription mechanism 
and nucleotide incorporation (Kettenberger et al., 2004; Wang et al., 2006; 
Westover et al., 2004). Even DNA damages could be co-crystallized with the 
12-subunit Pol II, leading to insights into damage recognition and lesion bypass 
by Pol II (Brueckner et al., 2007; Damsma et al., 2007).  
For Pol III, there is no crystal structure available, yet. However, the 17-subunit 
enzyme has been solved by cryo-EM to 17 Å (Fernandez-Tornero et al., 2007) 
and the Pol III-specific subcomplex C17/25 has been solved by X-ray 
crystallography (Jasiak et al., 2006) to 3.2 Å resolution. In addition, a homology 
model for 11 subunits of the enzyme could be constructed, which demonstrated 
that, despite sequence homology of about 40% across all subunits, 80% of the 
fold seems to be conserved between Pol II and Pol III. 
For Pol I, the overall shape and dimensions were first revealed by electron 
microscopy of 2-dimensional crystals (Schultz et al., 1993). Subsequent cryo-
EM at 34 Å resolution visualized a stalk density containing the Pol I subcomplex 
A14/43 and densities for the Pol I-specific subunits A49 and A34.5 over the 
central cleft (Bischler et al., 2002; Peyroche et al., 2002). Later EM analysis with 
negatively stained specimen at 22 Å confirmed the stalk, but not the location of 
A49 and A34.5 (De Carlo et al., 2003). 
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I.9 | Aim of this study 
 
As structural information to atomic resolution is limited to Pol II (Chapter I.8) and 
sequence identity between Pol I and Pol II is only 30% (this study), the aim of 
this work was to solve the structure of RNA polymerase I from Saccharomyces 
cerevisiae to atomic resolution by means of X-ray crystallography. 
The structure of this huge 600 kDa macromolecular complex would enable us to 
possibly explain promoter specificities between the eukaryotic RNA 
polymerases, to understand rDNA transcription and its regulation in atomic 
detail and to unravel evolutionary differences between the polymerase systems. 
Additionally, the two Pol I-specific subunits A49 and A34.5 and the distantly 
related subcomplex A14/A43 were expected to provide insights into Pol I 
transcription, which could in return broaden our knowledge about the Pol II 
system. Structural information on Pol II was expected to facilitate this enormous 
task, especially for phasing crystallographic data. 
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II.1 | Large-scale purification of RNA polymerase I 
 
Prior to crystallization, a large-scale purification protocol for Pol I had to be 
developed. This was based on a initially collaborative effort together with 
Jochen Gerber from the group of Herbert Tschochner at the University of 
Regensburg, Germany. 
Yeast fermentation was carried out until late-log phase (OD600 ~ 5), but later on 
during this thesis it was realized that even higher OD600 values up to ~ 9 did not 
make any difference in crystallizability of the protein sample. The strain used for 
purifying Pol I, GPY2, contained only a few genetic modifications compared to 
wild-type yeast. The genomic copy of the essential subunit A43 was knocked 
out and placed on a yeast plasmid for introducing a hemagglutinin (HA)- and 
hexahistidine-tag. The engineered strain grew like wild-type yeast with a 
doubling time of 2 – 2.5 hours (Fig. 6). Running a 200 L fermenter yielded 
typically 1.7 – 2.8 kg of yeast pellet that could be used for up to 6 Pol I 
purifications according to the protocol described here. 
 
 
 
Figure 6 | Growth curve of GPY2 in the small 20 L fermenter 
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Developing a purification protocol for Pol I proved to be a project posing many 
challenges: First, the purification protocol from our collaborators in Regensburg 
made use of the detergent NP-40, which was incompatible with crystallization 
trials. Second, up-scaling this initial protocol introduced lots of problems 
concerning reproducibility. Third, every purification step preceding the anion 
exchange column had to be assessed by western blotting, which made 
optimization very time consuming. Taken together, obtaining enough 
crystallization-quality material from endogenous expression was very difficult 
and remained the biggest problem throughout the whole project (Chapter III.1). 
For cell lysis BeadBeatersTM were superior to any other technique tested. 
Judging from cell debris versus non-broken cells, bead-beating was at least 
90% effective. The salt concentration before cell lysis was adjusted to 400 mM 
ammonium sulfate to prevent protein aggregation. Cell debris and non-lysed 
cells were removed by centrifugation. Lipids and chromatin were removed by an 
ultracentrifugation step at 100,000 x g using two swinging bucking rotors 
(~ 160 mL in each rotor). Lipids above the aqueous supernatant were aspired 
using a vacuum gadget. Care was taken in pooling the supernatant to prevent 
inclusion of DNA and chromatin, which formed a huge pellet after this 
ultracentrifugation step. 
The clear whole cell extract was dialyzed over night at 4 °C against low salt 
buffer (Milkereit et al., 1997; Tschochner, 1996). During this step, 
RNA polymerase I precipitated, whereas Pol II and Pol III stayed in the 
supernatant. The dialysed sample was ultra-centrifuged at 30,000 x g. By 
resuspending the pellet in reduced volume, Pol I could be incubated with Nickel 
resin in just 50 mL solution. For reasons of better reproducibility and higher 
protein yield, the Nickel resin was distributed between 2-4 smaller columns. 
Pol I was allowed to bind to the Nickel resin for 4 h at 4 °C in high salt buffer to 
prevent DNA and proteins from unspecific binding. Optimization of this affinity 
step was very difficult, as Pol I was very weakly bound to the resin with a 
substantial amount flowing through the column or sticking irreversibly to the 
column. 
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Pol I was eluted with 100 mM imidazole and was loaded onto an anion-
exchange column, applying the gradient shown in Fig. 7 and running the 
column at least twice to increase protein yield. 
 
 
 
 
 
 
Figure 7 | KOAc-gradient used for anion-
exchange chromatography. (first step to 
700 mM KOAc not always performed) 
 
 
As the theoretical pI value for Pol I is 6.25 it was expeted to bind to the anion 
exchange column. It eluted at approximately 1.1 M KOAc as the protein 
complex that was free of DNA. Fig. 8 shows an example of a MonoQ run. Pol I 
is still quite impure after this step but, nevertheless, this is the first step where it 
can be recognized on SDS-PAGE without western blotting. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 | Anion-exchange 
chromatography 
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The MonoQ peaks were pooled and diluted 5.5 times before they were loaded 
onto a small MonoS column (1 mL bed volume), using the same pH and slightly 
less salt as for the anion-exchange step. Attempts to use bigger columns failed. 
The elution gradient is shown in Fig. 9. 
 
 
 
 
 
 
 
Figure 9 | Gradient used for cation-
exchange chromatography 
 
 
Absolutely pure Pol I eluted in a sharp peak at 490 mM KOAc, being the protein 
that eluted last from the column (Fig. 10). 
 
 
 
Figure 10 | Cation-exchange chromatography. (A) Chromatogram. (B) SDS-PAGE of 
selected fractions. Flow-through was TCA precipitated, SDS marker with bands of 200, 116, 97, 
66, 45, 31, 21.5, 14.4 and 6.5 kDa. 
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Peak fractions were concentrated to 500 µL and applied to a pre-equilibrated 
size-exclusion column (Fig. 11). Pol I eluted at 11.9 mL, was monodisperse 
according to static light scattering, and was subsequently concentrated to 5.5 
mg/mL for crystallization. The average yield of the purification ranged from 0.4 
to 0.8 mg of pure Pol I. 
 
 
 
Figure 11 | Size-exclusion chromatography (and SDS-PAGE of pure Pol I) 
 
 
II.2 | Crystallization of Pol I 
 
Prior to having optimized the purification protocol, Pol I could be crystallized 
using a hand-made crystallization screen composed of known crystallization 
conditions for Pol II and a rather impure Pol I sample. Tiny crystals appeared in 
two conditions: The first contained 300 mM ammonium-sodium tartrate, 100 mM 
KSCN, 100 mM HEPES, pH 7.5, 12.5-14.5% PEG-6000 and 5mM DTT, the 
second contained 390 mM ammonium-sodium phosphate, pH 6.0, 50 mM 
dioxane, 14-15% PEG-6000 and 5 mM DTT (Fig. 12). Crystal size could only be 
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improved for the tartrate-KSCN based condition by using a protein: precipitant 
drop ratio of 2:1. Crystals diffracted to about 5.5 Å resolution and could be 
processed using DENZO from the HKL package (Otwinowski and Minor, 1997), 
resulting in a complete dataset in space group C2221 with unit cell axis of          
a = 222.4 Å, b = 395.3 Å and c = 282.0 Å. Data could be phased using 
PHASER (McCoy et al., 2005), but unfortunately no additional density separate 
of the 12-subunit Pol II was visible. However, the unit cell dimensions, the 
space group and the crystal shape were so similar to Pol II crystals that we 
suspected that these crystals contained Pol II rather then Pol I, which would 
perfectly explain the lack of additional density. Due to the poor purity of the 
initial Pol I preparations, it might well be that a small Pol II impurity crystallized 
instead of Pol I. Although this speculation was not unambiguously confirmed, 
gradually improving the purification protocol led to a complete loss of the initial 
crystals, supporting the argument that the crystals were indeed Pol II crystals. 
 
 
 
Figure 12 | Initial Pol I crystals. (A) First Pol I (?) crystals seen in a tartrate-KSCN droplet; 
12/2006. (B) First crystals in ammonium-sodium phosphate. (C) Optimized tartrate-KSCN 
crystals. (D) Diffraction pattern of ck26, recorded at SLS, May 2005. 
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Improving the Pol I purification led to huge problems with crystallization. After 
introducing the cation-exchange chromatography step to increase the purity of 
Pol I, crystals could no longer be obtained. Huge efforts in screening and 
optimizing the crystallization process resulted in 3% MPD as potent additive in 
inducing crystallization. Additionally, potassium thiocyanate had to be left out 
and ammonium-sodium tartrate was replaced by di-ammonium tartrate. After 
optimization, the reservoir solution contained 300 mM di-ammonium tartrate, 
100 mM HEPES, pH 7.5, 3% MPD, 10% PEG-6000 and 5 mM DTT or 3 mM 
TCEP. Even after having tried different protein : reservoir ratios, different 
temperatures, numerous oils and many other variables, crystals never got 
bigger than 100-150 µm in their largest dimension. 
At this point, streak-seeding (Bergfors, 2003) was the best solution to the size 
problem (at least in one dimension, Fig. 13A-C). Using cat-whiskers, Pol I 
crystallization could be triggered in pre-equilibrated drops (equilibration time 3-4 
hours), using precipitant solution with a reduced PEG-6000 concentration of 9% 
(initially 10%) and a protein concentration of 2 to 4 mg/mL (initially 5.5 mg/mL) 
(Chapter III.3.2). As seeding was very sensitive to the amount of nuclei 
introduced, reproducibility remained a serious problem. Crystal size seemed to 
be affected by a myriad of factors like the initial cell material, protein purification, 
equilibration time, seeds’ freshness, the cat-whisker used etc. Increasing the 
precipitant concentration by just 0.5% resulted in no crystals or very small ones. 
Despite this sensitivity, single crystals reached a maximum size of 500 µm x 70 
µm x 10 µm (Fig. 13D). 
 
 
 
 
 
 
 
 
 
Part II: Results and Discussion 
 21 
 
 
 
 
 
 
 
 
 
 
Figure 13 | Improved 
Pol I crystals.  
(A) and (B) Streak- 
seeding examples.  
(C) Nucleation after 
seeding too high.  
(D) Crystal > 400 µm 
(in one dimension). 
 
 
II.3 | Cryo-crystallography and heavy atom derivatization 
 
After initial non-satisfying trials with glycerol, sucrose and L-(+)-2,3-butandiol, 
22% PEG-400 was used as cryo-agent. Native crystals grown in seeded drops 
never showed ordered diffraction. Heavy atom derivatization, persecuted for 
gaining experimental phase information, proved to be essential for introducing 
order in the crystal lattice (Fig. 14). 
Soaking of crystals in the final cryo-solution in the presence of a W18 cluster for 
~ 2 days resulted in optimal diffraction. See Table 2 for a summary of all heavy 
atom clusters and manipulation techniques tried and their effects on Pol I 
crystal diffraction quality. Heavy atoms were always added after having 
transferred the crystals to the final cryo-solution. 
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Figure 14 | Improvement of diffraction quality upon heavy atom treatment. (A) Native 
crystal without W18 treatment. (B) Crystal soaked for 2 days in W18 solution (Note: Crystals are 
not the same). 
 
 
Table 2 | Summary of heavy atom derivatization protocols 
 
Heavy atom Soaking protocol Additional manipulation Result 
-  Cross-linking using  
glutaraldehyde 
No improvement 
versus native crystals. 
W18 cluster Overnight at 4 °C or      
20 °C 
- Still diffraction like 
native crystals. 
W18 cluster 44 h at 4 °C - Best data quality. 
W18 cluster 44 h at 4 °C Cross-linking using  
glutaraldehyde 
(optional backsoaking) 
Very high resolution 
for first frames, but too 
much radiation 
damage to collect full 
dataset. 
W18 cluster 44 h at 4 °C Dehydration by 
increasing PEG-6000 
to 20% 
Diffraction quality 
much poorer. 
W18 cluster 66 h at 4 °C - Diffraction quality 
diminished (compared 
to 44 h soaking). 
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W30 cluster 44 h at 4 °C (Optional : cross-linking 
using glutaraldehyde) 
Heavy atom treatment 
apparently destroys 
diffraction. 
Ta6Br122+ cluster 1-3 h at 20 °C - No ordered diffraction 
beyond 6-7 Å. 
Ta6Br122+ cluster Overnight (Optional : cross-linking 
using glutaraldehyde) 
Very poor diffraction, 
most crystals dead. 
Ir3 cluster 2-3 h at 20 °C - Diffraction quality OK, 
derivatization not 
optimized. 
W6Br122+ 1-2 h or overnight - No ordered diffraction 
beyond 6-7 Å, 
derivatization not 
optimized. 
2,4,6-Trisaceto-
(3-acetamino) 
mercuritoluol 
½ - 3 h at 20 °C - No diffraction at all. 
 
 
II.4 | Data collection and processing 
 
All datasets were collected at the SLS (Swiss Light Source) on beamlines 
X06SA and X10SA. The presence of heavy atoms in the crystals was 
demonstrated by performing X-ray absorption scans for every heavy atom 
species used (Fig. 15). Due to severe problems with radiation damage, deriving 
a perfect strategy for data collection was crucial (Chapter III.4). 
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Figure 15 | Data collection of crystals soaked with heavy atoms. (A) Experimentally derived 
f’ and f’’ values for W18 at the L-III edge. (B) Ta6Br122+ soaked crystal. (C) W18 soaked crystal. 
 
 
Processing the data with DENZO and SCALEPACK (Otwinowski and Minor, 
1997) resulted in reasonable statistics to 4.8 Å (Chapter III.5). The unit cell was 
monoclinic C2, with unit cell dimensions of a = 615 Å, b = 304 Å, c = 253 Å and 
β = 97.6°. 52,205 reflections of the measured 1,237,240 were rejected (4.2%), 
the average redundancy being > 5. Striking was the high R-factor in the lowest 
resolution shell. We speculate that this is due to the anomalous signal of the 
W18 cluster, which is unfortunately not bound to the protein, but diffuses freely in 
the solvent channels of the crystal (Fig. 16C). 
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Figure 16 | Diffraction pattern of W18 soaked crystals and data statistics. (A) Image of 
crystal ck284 (44 h W18 at 4 °C). (B) Image of crystal ck290 (44 h W18 at 4 °C). (C) Data 
statistics of ck290 (after SCALEPACK). 
 
Even though heavy atom derivatization and data collection were quite 
sophisticated for Pol I, the main problem was a lack of reproducible crystals. 
Microseeding did not produce lots of suitable crystals, it was very difficult to 
standardize and the crystals got the bigger the fewer grew in one drop. With this 
small amount of crystals, choosing the right cryo-agent, heavy atom treatment 
or data collection strategy was very risky. 
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II.5 | Attempts on solving Pol I by X-ray crystallography 
 
Calculating the Matthews coefficient for Pol I crystals suggested four copies in 
the asymmetric unit, when assuming the same solvent content as in Pol II 
crystals (75%). However, after calculating a self-rotation function with the Pol I 
data, the situation became even more dramatic (Chapter III.5). At κ = 52° a very 
strong peak could be observed, complemented by 7 equally strong peaks at κ = 
180°. This strongly suggested the existence of 7 Pol I molecules in the 
asymmetric unit related by a 7-fold non-crystallographic symmetry (NCS) axis 
with 14 2-fold axes perpendicular to the 7-fold (One 2-fold axis every 25°). In 
standard stereographic projections, these 14 axes result in just 7 axes plotted in 
one polar coordinate hemisphere (Fig. 17). The 7-fold axis of this NCS 
ensemble is oriented along c. These findings demonstrate that the asymmetric 
unit of Pol I crystals contains 600 kDa x 7 = 4.2 MDa of protein (56% solvent). 
This is not much less than the asymmetric unit of the E.coli 70S ribosome, 
which contains 2 ribosomes (5.6 MDa) in the asymmetric unit (Schuwirth et al., 
2005)! 
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Figure 17 | Non-crystallographic organization of the Pol I asymmetric unit. (A) 
Stereographic projection of the self-rotation function at κ = 51° (7-fold NCS axis). (B) 
Stereographic projection at κ = 180° (2-fold NCS axes). (C) Sketch of the inherent symmetry of 
the Pol I asymmetric unit. The 14 2-fold axes lie in the ab plane, perpendicular to the page. 
 
Two approaches for solving the Pol I crystal structure were pursued: First, 
heavy atom derivatization using cluster compounds for deriving experimental 
phase information. Second, molecular replacement using either models based 
on available Pol II crystal structures or structural information gained by cryo-
electron microscopy. 
A fortunate side effect of treating crystals with heavy atoms was the discovery 
that W18 ordered Pol I crystals in a quite unique way and eventually enabled 
data collection to 4.8 Å. However, binding heavy atom clusters to Pol I was 
fairly unsuccessful. Neither classical anomalous difference Patterson maps nor 
software like SOLVE (Terwilliger and Berendzen, 1999), SHELXD (Schneider 
and Sheldrick, 2002) or BnP (Furey and Swaminathan, 1997; Weeks et al., 
1994) revealed unambiguous heavy atom sites (Chapters III.6.1 and IV.3).    
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The anomalous signal is greatly reduced at about 30-40 Å resolution (high 
Rmerge in low resolution shell, Fig. 16C), one possible explanation for that being 
that W18 is not stably bound but rather diffused through the crystals’ solvent 
channels. How the cluster would specifically order the crystal without 
specifically binding to the protein will remain a mystery.  
Molecular replacement was initially carried out using models based on the Pol II 
structure, using either the complete 12-subunit enzyme (Armache et al., 2005) 
or Pol II bound to TFIIS (Kettenberger et al., 2003) as search models. 
Sequence elements of Pol II that were apparently divergent or missing in Pol I, 
were omitted according to Chapter IV.7. However, using these models in 
molecular replacement never resulted in groups of seven rotational solutions 
representing the expected 7-fold axis in the asymmetric unit. Using the known 
self-rotation information as restraint in the program MOLREP did at least result 
in some rotational solutions that were related by a 7-fold axis, but a full set of    
7 clustered solutions could never be obtained using crystallographic models 
(Fig. 18A). 
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Figure 18 | Solutions of the Molecular replacement rotation function. (A) Using a 
crystallographic model and ck209 data. (B) Using an EM map (val067f_300.map) and ck290 
data. Red asterisks highlight rotational solutions related by a 7-fold axis. 
 
After having solved the Pol I structure by cryo-electron microscopy to 11.9 Å 
(Chapters II.6 and III.7), molecular replacement with MOLREP was tried again, 
using the EM density map as search model, which resulted for the first time in 
clusters of 7 rotation solutions that were related to each other by a 7-fold axis 
(Fig. 18B and Chapter IV.4). However, solving the translation function for these 
pairs of seven solutions was not possible.  
In ongoing research we are trying to restrain the translational search by 
constructing search models that already consist of seven Pol I molecules (Fig. 
19). These   7-mer rings are constructed by applying each rotation onto the 
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search model, in this case an EM density map. The resulting seven rotated 
molecules are easily combined to form ‘common sense’ rings, which still obey 
all restraints imposed by NCS and the unit cell dimensions. We will hopefully 
one day see phased Pol I density after finally having elucidated this complicated 
asymmetric unit or by finding a different crystallization condition with simpler 
non-crystallographic symmetry. However, if one could solve this complicated 
asymmetric unit, we could exploit the enormous power of phase improvement 
by 7-fold NCS-averaging. 
 
 
 
 
 
Figure 19 | Potential 7-mer 
ring. Molecules were rotated 
by applying the 7 rotational 
solutions onto a Pol II model 
fitted into the EM density. 
Molecules were shifted to 
form a 7-mer ring – in this 
example we chose to orient 
A14/43 towards the center 
of the ring. One A14/43 
complex is marked with a 
white circle. 
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II.6 | Cryo-EM structure of Pol I at 12 Å resolution 
 
The to-date unsuccessful crystallographic structure solution of Pol I prompted a 
collaboration with the group of Roland Beckmann from the FU Berlin (now Gene 
Center, Munich), using electron microscopy instead of X-ray crystallography for 
structure solution. Pol I was purified as described for crystallization (Chapter 
III.1) and kept on ice until further usage. The optimal protein concentration for 
cryo-EM, 0.1 mg/mL, was determined by electron microscopy using negative 
stain (Chapter III.7.1 and Fig. 20A). Particles did not form aggregates and 
showed high particle density. Even under cryo-conditions (100K at liquid 
nitrogen temperatures) particles could be easily identified and apparently 
behaved nicely during vitrification (Fig. 20B). Cryo-EM reconstruction of Pol I 
(Chapter III.7.4) with 46,056 particles led to a map at 11.9 Å resolution (Fig. 
20C, D). 
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Figure 20 | EM reconstruction of Pol I. (A) Negatively stained Pol I. (B) Pol I variant Δ49/34.5 
under cryo conditions. (C) Cryo-EM reconstruction of Pol I. Views and structural regions are 
named according to the Pol II structure (Cramer et al., 2001). (D) Fourier shell correlation (FSC) 
function plot. Based on a cutoff value of FSC=0.5, the resolution is 11.9 Å. 
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Interpretation of the EM map was achieved by first placing the crystal structure 
of the 10-subunit core into the EM map as a rigid body by fitting the five 
common subunits, which were known to occupy similar positions on the 
polymerases’ surfaces (Jasiak et al., 2006). A perfect fit of the common 
subunits confirmed the high quality of the map (Fig. 21).  
 
 
 
Figure 21 | Placement of 10-subunit Pol II into EM density. (A) Placement of the Pol II 10-
subunit core structure (Armache et al., 2005) (grey) into the EM density (blue). The foot was 
deleted, and subunits Rpb5, Rpb8, and Rpb9 are highlighted in magenta, green, and orange, 
respectively. The clamp has been fitted as a separate rigid body. (B) Fit of the common 
subunits Rpb5 and Rpb8 to the EM map, and density for the core subunit A12.2 (the Pol II 
homolog Rpb9 is shown as a ribbon model). 
 
Many regions of the homologous subunits fitted equally well, but strong 
deviations were also observed, in particular at the polymerase clamp and foot 
(Cramer et al., 2001) (Fig. 24). The clamp had swung inwards, entirely closing 
off the cleft (Fig. 22A). This closed clamp conformation is the predominant state 
of the enzyme under the used experimental conditions, as the sample 
contained polymerases with many different clamp conformations. In a large 
fraction of these particles, the clamp apparently adopted a totally closed state, 
which allowed for refinement of the class I volume to high resolution (Chapter 
III.7.4). However, several different clamp conformations were apparently 
present in class II, impairing refinement of the volume to high resolution.       
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The absence of bias during reference-based alignment could be demonstrated 
using a Pol II structure lacking the clamp, Rpb4/7 (except for the Rpb7 tip 
domain) and the foot domain. Already after initial alignment, density for the 
clamp reappeared and confirmed thereby the validity of our alignment 
approach. To exclude that the small stalk density was due to just the tip domain 
of Rpb7 being present, reference-based alignment was carried out again, using 
a model that contained the complete Rpb4/7. Again, after the first round of 
refinement, the density for Rpb4/7 was strongly decreased and was lacking at 
the outer positions (Fig. 22B). This is a clear indication that less density for the 
Rpb4/7 counterpart A14/43 in Pol I is not due to reference bias but reflects a 
high mobility of the OB domain of A43 and the absence of an HRDC domain 
(Chapter II.8).  
 
 
 
Figure 22 | Clamp flexibility and absence of reference-bias. (A) Schematic representation of 
the clamp positions in Pol I, the complete 12-subunit Pol II (Armache et al., 2005), and the 10-
subunit core Pol II (Cramer et al., 2001). (B) Comparison of the reference including Rpb4/7 
(green) to the volume obtained after the first round of refinement (blue). Both volumes are 
filtered at 20 Å.  
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II.7 | Homology model of the Pol I core explains EM density 
 
To explain differences between the EM map and the Pol II core structure, we 
constructed a homology model for the Pol I core. Modeling was achieved as for 
the Pol III core (Jasiak et al., 2006), but was complicated by the weaker 
sequence conservation between Pol II and Pol I subunits (Fig. 23, Table 3 and 
Chapter IV.7). We identified regions of conserved fold in cycles of sequence 
alignment, model construction, detection of incorrect internal contacts, 
realignment of the erroneous sequence stretches, and the construction of an 
improved model (Fig. 23, Chapter IV.7). In the Pol I core model, well-conserved 
regions cluster around the active site, and peripheral regions are divergent 
(Chapter IV.7). However, some peripheral Pol I domains, such as the jaw and 
lobe, resemble in shape the Pol II domains, suggesting that their folds are 
conserved despite divergent sequences. The predicted conservation of Pol II 
folds is far less in Pol I (60.8% overall, Table 3) than in Pol III (83.4% for a 11-
subunit model (Jasiak et al., 2006)). 
 
 
 
Figure 23 | Homology model of the Pol I core. Pol II structure-guided sequence alignment of 
the five Pol I subunits with homologs in Pol II (compare Table 3). The domain organization of 
Pol II subunits Rpb1, Rpb2, Rpb3, Rpb11, and Rpb9 is shown as diagrams (Cramer et al., 
2001). Insertions and deletions exceeding five amino acid residues are indicated. Conserved 
folds are indicated by orange highlighting of the bar above the diagrams. 
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Table 3 | Sequence and fold conservation between Pol I and Pol II 
 
Polymerase 
part 
Pol I subunit Pol II subunit 
Sequence 
identity1 (%) 
Conserved Pol II 
fold2 (%) 
A190 Rpb1 22.3 47.8 
A135 Rpb2 26.0 62.1 
AC40 Rpb3 21.2 53.5 
AC19 Rpb11 17.6 77.5 
A12.2 Rpb9 19.2 35.2 
Rpb5 (ABC27) Rpb5 100 100 
Rpb6 (ABC23) Rpb6 100 100 
Rpb8 (ABC14.5) Rpb8 100 100 
Rpb10 (ABC10b) Rpb10 100 100 
Core 
Rpb12 (ABC10a) Rpb12 100 100 
A14 Rpb4 4.5 25.03 Subcomplex 
A14/43 A43 Rpb7 8.0 78.43 
A49 RAP744 7.6 57.2 Subcomplex 
A49/34.5 A34.5 RAP304 8.3 80.5 
Total - - 29.5 60.8 
 
1Number of amino acid residues in the Pol I subunit that are identical in the corresponding Pol II 
subunit divided by the total number of residues in the Pol I subunit. For A49/34.5, number of 
amino acid residues in the TFIIF RAP74/30 dimerization module structure that are identical in 
the A49/34.5 model divided by the total number of residues in the RAP74/30 heterodimer 
structure (Gaiser et al., 2000). 
2Number of amino acid residues in the Pol II core structure that have the same fold in the Pol I 
homology model divided by the total number of residues in the Pol II subunit.  
3For A43, number of amino acid residues in the Rpb7 structure that have the same fold in the 
A43 structure divided by the total number of residues in the Rpb7 structure. For A14, number of 
amino acid residues in the Rpb4 structure that have the same fold in the A14 structure divided 
by the number of residues of the tip-associated domain of Rpb4 (residues 1-155, HRDC domain 
excluded). 
4Predicted to be partially homologous to the TFIIF subunits RAP74 and RAP30. For details see 
Chapter III.10. 
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Inspection of the EM map after placement of the core model confirmed the 
expected conservation of the active center, including the bridge helix, but also 
identified many structural features that create a Pol I-specific surface. The 
clamp shows two insertions near zinc site 7 (“clamp knob”), and an extended, 
structurally different clamp head (Figs. 20C, 24B). The dock domain shows 
density for a predicted (Chen and Hahn, 2003) Pol I-specific 14-residue 
extension (Fig. 24). In AC40, two surface elements differ from Rpb3 (Fig. 24). 
The foot domain has a divergent sequence, is 62 residues shorter, and has a 
different shape than in Pol II (Fig. 24). The jaw region contains 93 additional 
residues (Fig. 23), which are not conserved among fungi, and lack EM density, 
showing they are mobile. A12.2 occupies the location of the Pol II core subunit 
Rpb9, and is thus a structural counterpart of Rpb9, not TFIIS (Fig. 21B), even 
though the C-terminus of A12.2 can be perfectly aligned to TFIIS (Chapter IV.7). 
 
 
 
Figure 24 | Pol I specific features of the EM density. (A) View of the core Pol II structure 
from the side, with domains depicted in (B) highlighted. (B) Pol I-specific structural elements. 
Fitted Pol II elements are shown as ribbon models. Insertions and deletions explaining the EM 
density are named according to Fig. 23. The clamp head is in light red, the clamp core in red. 
The dock and foot domains are in beige and blue, respectively, and Rpb3, Rpb10, and Rpb11 
are in red, dark blue and in yellow, respectively. Zinc ions are depicted as marine spheres. 
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II.8 | Crystal structure of A14/43 elucidates Pol I initiation 
 
After assigning EM densities to the Pol I core, a stalk-like density remained at 
the expected location for A14/43 that was much smaller than the structure of 
Rpb4/7 (Figs. 20C, 22). Since the weak sequence similarity between A14/43 
and Rpb4/7 or C17/25 did not allow for homology modeling, we determined in a 
long-term project the crystal structure of A14/43. Structure determination of 
A14/43 will not be part of this thesis, however, information gained from the 
structure explaining Pol I function will be discussed.  
The overall structure of A14/43 resembles its counterparts Rpb4/7 (Armache et 
al., 2005), C17/25 (Jasiak et al., 2006), and the archaeal RpoF/E , except that 
A14 lacks the HRDC domain present in all counterparts (Fig. 25). The N-
terminal tip domain of A43 shows RMS deviations in Cα atom positions of 2.2-
2.5 Å, whereas the C-terminal OB domain is more divergent. A14 forms two 
helices that pack on the A43 tip domain (Fig. 25). 
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Figure 25. X-ray structure of the A14/43 subcomplex. (A) Structure of yeast A14/43 (this 
study). A43 is in bue, A14 in red. (B) Structure of yeast Rpb4/7 (Armache et al., 2005). Rpb7 is 
in blue and Rpb4 is in red, with the HRDC domain in light red. (C) Fit of the A14/43 structure 
into the Pol I EM density. (D) Fit of the Rpb4/7 structure into Pol I EM density. 
 
In Pol II, the Rpb4/7 complex interacts with the core enzyme via two loops, the 
A1-K1 loop, which forms a conserved contact of Rpb4/7-like subcomplexes with 
their cognate core enzymes, and the tip loop, which may confer specificity to 
the interaction in the different RNA polymerases. To dock the A14/43 structure 
into the EM map, we modeled the conserved contact between an invariant 
proline residue in the A1-K1 loop (P51 in A43, Fig. 25A) and the common core 
subunit Rpb6. The tip domain and the tip-associated domain of the A14/43 
structure fitted well to the EM map, and the lack of an HRDC domain could in 
part explain the smaller EM density (Fig. 25C+D). However, the peripheral OB 
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domain of A43 was not revealed in the EM density (Fig. 20C), suggesting a high 
degree of mobility. Consistently, the OB domain shows slightly higher B-factors 
in the crystal structure although it is involved in crystal contacts (not shown), 
and normal mode analysis of the Pol II crystal structure shows that the OB 
domain is the most flexible region of the enzyme. The A43 tip loop contains a 
specific ten-residue insertion that may confer specificity to the interaction 
between A14/43 and the Pol I core. The A43 tip loop is flexible in the crystal 
structure (Fig. 25A), but is likely folded upon binding to the Pol I core, as 
observed for Pol II (Armache et al., 2005). 
Subunit A43 forms an essential bridge to the conserved Pol I initiation factor 
Rrn3 (Milkereit and Tschochner, 1998; Peyroche et al., 2000). Rrn3 was shown 
by EM to co-localize with A43 (Peyroche et al., 2000), and binds other initiation 
factors to recruit Pol I to the rDNA promoter. The A43-Rrn3 interaction is 
conserved in human (Yuan et al., 2002) and S. pombe (Imazawa et al., 2005). 
In a Pol I variant that is defective for Rrn3 interaction (rpa43-6, (Peyroche et al., 
2000)), two out of three altered A43 residues map near conserved residues on 
the upstream surface of A14/43. Thus Rrn3 binds to A14/43 from the upstream 
side (Fig. 20C). Additional Pol I-specific surfaces in the vicinity include the 
extended dock domain and the clamp knob, which together with A14/43 create 
a specific upstream face for Pol I initiation complex assembly (Figs. 20, 24). 
Differential initiation factor interactions and promoter-specificity of the three 
polymerases may generally result from differently structured dock domains, 
clamps, and Rpb4/7-like subcomplexes, which all constitute initiation factor 
binding sites. Rpb4/7 is required for Pol II initiation (Edwards et al., 1991). 
C17/25 binds to the Pol III initiation factor TFIIIB (Ferri et al., 2000), to the 
subcomplex C82/34/31 that bridges to TFIIIB (Bartholomew et al., 1993), and to 
the initiation factor TFIIIC (Hsieh et al., 1999). Since the surfaces, flexibility, and 
in vivo function of the HRDC domains differ in Rpb4/7 and C17/25 (Jasiak et al., 
2006), the absence of an HRDC domain in A14/43 is likely to be functionally 
significant. 
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II.9 | A49 and A34.5 act as built-in, heterodimeric elongation factor 
 
After assigning EM densities to the Pol I core and A14/43, one additional large 
density remained on the enzyme surface that was assigned to the Pol I-specific 
subunits A49 and A34.5 (Fig. 20C). To confirm this assignment, we dissociated 
subunits A49 and A34.5 from Pol I with the use of urea (Huet et al., 1975), 
purified the resulting 12-subunit variant Pol I ΔA49/34.5 (Chapter III.2), and 
solved its structure by cryo-EM at 25 Å resolution (Fig. 26 and Chapter III.8). 
The structure was similar to the complete Pol I, except that the density assigned 
to A49 and A34.5 was lacking (Fig. 26B). In addition, there was a minor change 
in the clamp conformation, which probably represents an average clamp 
position, and is unlikely to result from the absence of A49/34.5 (Chapter III.8). 
Density assigned to A49 and A34.5 is located near the enzyme funnel, the 
external domain 1, a conserved core loop with a Pol I-specific insertion 
(corresponding to loop α16-β20 of the Pol II pore domain), and A12.2. This is 
consistent with loss of A49 when Pol I is purified from A12.2 deletion strains 
(Van Mullem et al., 2002). 
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Figure 26 | Cryo-EM structure of A49/34.5. (A) SDS-PAGE analysis of the variant Pol I 
∆A49/34.5 (right), obtained by urea treatment of the complete Pol I (left). (B) Overlay of EM 
structures of Pol I ∆A49/34.5 (silver surface) and the complete Pol I (blue). The density 
assigned to A49/34.5 is highlighted in green.  
 
To investigate the structure and function of A49 and A34.5 we searched for 
weak homologies with HHpred (Soding et al., 2005). Local homologies were 
detected between A49 and RAP74, the large subunit of the Pol II-associated 
factor TFIIF, and between A34.5 and RAP30, the small TFIIF subunit (Fig. 27 
and Chapter III.10). Consistently, the N-terminal regions of A49 and A34.5 were 
predicted to contain β-strands consistent with the fold of the RAP74-RAP30 
dimerization module (Gaiser et al., 2000), and hydrophobic core residues in this 
fold were predicted to be conserved (Fig. 27). Consistent with these predictions, 
bacterial co-expression of A49 and A34.5 enabled isolation of a stoichiometric 
A49/34.5 heterodimer (Fig. 28A and Chapter III.11), and alanine point mutations 
in three different conserved hydrophobic residues in the dimerization interface 
(I12 and Y76 in A49, W54 in A34.5) abolished or strongly impaired A49-A34.5 
co-purification (Fig. 28B-D). Thus, A49 and A34.5 form a stable TFIIF-like 
heterodimerization module. 
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Figure 27 | (A) Sequence alignments of S. cerevisiae A49 and A34.5 with their putative 
counterparts in H. sapiens TFIIF (RAP74 and RAP30, respectively). Sequence similarity is only 
observed in the N-terminal part of both proteins (residues 1-166 in RAP74 and residues 1-118 
in RAP30). Secondary structure elements are shown above the sequences (broad lines, α-
helices; arrows, β-strands; lines, loops). Conserved residues are highlighted according to 
decreasing conservation from green, through orange, to yellow. Residues involved in a 
conserved core interaction are marked with a C below the sequence, while charged residues 
forming a salt bridge are depicted in blue and red, respectively. Secondary structure elements 
are depicted above the RAP74/30 sequences, according to structural information (Gaiser et al., 
2000). For clarity, the symbols a/b are used in RAP74, α/β in RAP30. For A49 and A34.5, 
predicted secondary structure elements are depicted in dark green (aligned by HHpred), light 
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green (predicted to be present by secondary structure propensity) and grey (not predicted to be 
present). (B) Conservation of the TFIIF RAP74/30 dimerization module in A49/34.5. Secondary 
structure elements aligned to RAP74/30 are highlighted in dark and light green, respectively. 
For details see (A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28 | Hydrohobic core point 
mutations. (A) Recombinant wild-type 
A49/34.5. (B) W54A mutant in A34.5. (C) I12A 
mutant in A34.5. (D) Y76A mutant in A49. 
 
Heterodimerization is consistent with the observed continuous EM density, 
which reconciles previous EM data. Initial cryo-EM showed two separated 
densities over the cleft that were assigned to A49 and A34.5 (Bischler et al., 
2002). EM at higher resolution did not confirm these densities, but revealed a 
new additional density (De Carlo et al., 2003) that was close to the location of 
A49/34.5 found here. The location of A49 and A34.5 distant from the DNA-
binding cleft explains why neither A49 nor A34.5 could be crosslinked to DNA in 
Pol I initiation complexes (Bric et al., 2004). 
The location of A49/34.5 at the Pol I funnel deviates from that of TFIIF on Pol II 
as observed by cryo-EM (Chung et al., 2003), but is more consistent with 
protein-protein cross-linking that maps TFIIF to the polymerase lobe and outer 
surface near Rpb9 (Chen et al., 2007). Discrepancies in the location of 
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A49/34.5 and TFIIF may be explained by different locations of a related 
dimerization module on the two polymerases, or by the presence of additional, 
unrelated domains in both factors. Sequence analysis showed that A49/34.5 
and TFIIF possibly have a counterpart in Pol III, the C37/53 heterodimer, which 
may occupy a similar location on the Pol III surface near the lobe and funnel 
(Fernandez-Tornero et al., 2007). 
The apparent homology of the A49/34.5 heterodimer with the N-terminal 
regions of the two large TFIIF subunits suggested that A49/34.5 has elongation-
stimulatory activity. We therefore compared the complete Pol I with Pol I 
ΔA49/34.5 in an RNA extension assay using a minimal DNA-RNA scaffold 
(Chapter III.13.1). The complete Pol I extended the RNA to the end of the 
template, whereas Pol I ΔA49/34.5 did not produce the run-off product         
(Fig. 29A). Addition of recombinant A49/34.5 rescued the defect of Pol I 
ΔA49/34.5, and enabled elongation to the end of the template (Fig. 29A,       
lane 4). We repeated the elongation experiments using a complete, 
complementary transcription bubble scaffold (Fig. 29B and Chapter III.13.2) 
(Kireeva et al., 2000). The complete Pol I produced the run-off transcript (+18), 
whereas Pol I ΔA49/34.5 did not, but addition of recombinant A49/34.5 
heterodimer restored run-off formation (Fig. 29B, lanes 6+7). The defect was 
not due to differential binding of the polymerase variants to the scaffold, as it 
was also observed when the elongation complexes were covalently coupled to 
magnetic beads and extensively washed before the reaction (not shown). 
Reduced elongation activity in the fully complementary system arises from a 
more sophisticated complex assembly, resulting in a higher proportion of RNA 
not bound to Pol I. Taken together, A49/34.5 is required for normal elongation 
activity of Pol I in vitro. 
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Figure 29 | Elongation-stimulatory activity of A49/34.5. (A) A49/34.5 shows elongation-
stimulatory activity in RNA extension assays with a minimal nucleic acid scaffold. The 
fluorescent label 6-carboxy-fluoresceine (FAM) on the RNA 5’-end is indicated. The times molar 
excess of added factors are indicated above the lanes. For lane 4, Pol I ΔA49/34.5 was 
complemented with a fivefold molar excess of recombinant A49/34.5 for 10 min at 20 °C prior to 
addition of the scaffold. (B) Elongation assay as in (A) but with a complete complementary 
bubble (Kireeva et al., 2000). 
 
To test whether A49/34.5 may have elongation-stimulatory function in vivo, we 
investigated if the growth phenotype of a yeast strain that lacked the gene for 
A34.5 (ΔA34.5) is affected when nucleotide supply was limited due to the 
presence of 6-azauracil (6AU). 6AU sensitivity is an indicator for Pol II-
associated elongation factor function in vivo, and recently also identified a Pol I 
mutant defective in rRNA elongation (Schneider et al., 2007). Whereas the wild 
type and ΔA34.5 strains did not show a growth difference on normal media, the 
ΔA34.5 strain showed a mild slow-growth phenotype on 6AU-containing media 
(Fig. 30). This suggested that A49/34.5 is required for normal RNA elongation 
by Pol I also in vivo. The elongation-stimulatory activity may be due to an 
allosteric effect, or due to an extension from A49/34.5 into the active center, but 
we cannot distinguish between these possibilities with the available structural 
data. 
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Figure 30 | Elongation activity of Pol I in vivo. 
Deletion of the gene for A34.5 leads to a 6-
azauracile-sensitive phenotype. From left to right 1:10 
dilution series are shown. As a control, cells were 
spread onto SDC plates containing uracil. 
 
 
II.10 | Pol I has intrinsic RNA cleavage activity that requires A12.2 
 
The active site of Pol II exhibits weak 3’-RNA cleavage activity that is stimulated 
by TFIIS (Wind and Reines, 2000). For Pol I, a RNAse H-like nuclease activity 
was initially described (Huet et al., 1976), but was later found to reside in a 
dissociable factor (Huet et al., 1977; Tschochner, 1996). To clarify whether Pol I 
possesses intrinsic RNA cleavage activity, we assembled a “backtracked” 
elongation complex from purified Pol I and a DNA-RNA scaffold that contained 
an RNA 3’-overhang (Fig. 31 and Chapter III.13.3). Incubation of the 
backtracked complex with 8 mM magnesium ions led to efficient shortening of 
the RNA from the 3’-end (Fig. 31B, lanes 1-3 and Chapter III.13.3). In more 
detail, Pol I mainly removed four nucleotides from the RNA, consistent with 
binding of the terminal hybrid base pair to the nucleotide insertion site (+1), 
extrusion of the RNA 3’-overhang into the polymerase pore, and cleavage of the 
phosphodiester bond between nucleotides at positions –1 and +1. In 
comparison, Pol II was unable to cleave the RNA under these conditions, but 
addition of TFIIS resulted in cleavage (Fig. 31B, lanes 8-11). The Pol II-TFIIS 
complex removed three or four nucleotides, indicating that a mixture of 
complexes was present with the terminal hybrid base pair occupying either 
position -1 or +1. Taken together, Pol I has a strong intrinsic RNA cleavage 
activity not present in Pol II.  
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The intrinsic cleavage activity likely escaped detection previously since the 
nucleic acid substrates used in published studies did not allow for the formation 
of a backtracked state, from which cleavage occurs. The previously described 
dissociable factor (Huet et al., 1977; Tschochner, 1996) may not be required for 
cleavage per se, but may induce backtracking of Pol I, to create a state of the 
elongation complex that is prone to cleavage. 
 
 
 
Figure 31 | Intrinsic RNA cleavage activity of Pol I. (A) DNA-RNA hybrid scaffold used in 
cleavage assays. (B) Comparison of RNA cleavage by Pol I variants with Pol II and the Pol II-
TFIIS complex. (C) pH-Dependence of Pol I cleavage activity.  
 
Additional cleavage assays showed that the Pol I variant ΔA49/34.5 cleaved 
RNA less efficiently than the complete Pol I (Fig. 31B, lanes 4+5). Cleavage 
stimulation by A49/34.5 is consistent with an early investigation of an RNAse H-
like activity in Pol I-containing fractions (Huet et al., 1976). We also asked 
whether subunit A12.2 is required for cleavage, since its counterpart C11 is 
essential for cleavage activity of Pol III (Chedin et al., 1998; Whitehall et al., 
1994). A Pol I variant lacking residues 79-125 of A12.2 (A12.2ΔC, Chapter III.2) 
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was totally inactive in RNA cleavage (Fig. 31B, lanes 6+7), but bound the 
nucleic acid scaffold in electrophoretic mobility shift assays (Fig. 32A and 
Chapter III.13.4), and retained elongation activity (Fig. 32B). Consistent with a 
function specific for the A12.2 C-terminal domain, a truncation variant remains 
bound to Pol I and does not show a conditional growth defect (Van Mullem et 
al., 2002). 
The A12.2 C-terminal domain shows homology to the TFIIS C-terminal domain 
that inserts into the Pol II pore to stimulate RNA cleavage (Kettenberger et al., 
2003), but its location in Pol I corresponds to that of the Rpb9 C-terminal 
domain on Pol II (Fig. 21B). Although the long linker between the A12.2 N- and 
C-terminal domains (Chapter IV.7) could in principle allow swinging of the       
C-terminal domain into the pore, our results suggest that the effect of A12.2 
truncation on cleavage is due to an allosteric rearrangement in the Pol I active 
center. This effect might be mediated by the trigger loop of Pol I, since it is in 
close proximity to the C-terminal domain of A12.2. Mutation of the residues in 
A12.2 homologous to the catalytical D53 and E54 in TFIIS leads to a lethal 
phenotype, demonstrating their importance (not shown, data by Jochen Gerber, 
Regensburg). The conserved polymerase active site is capable of RNA 
cleavage in the absence of cleavage stimulatory factors, since free Pol II and 
the bacterial RNA polymerase can cleave RNA under mild alkaline conditions 
(Orlova et al., 1995; Weilbaecher et al., 2003). Consistently, the intrinsic 
cleavage activity of Pol I increased with increasing pH (Fig. 31C). The structural 
basis of the effect of A12.2 truncation on RNA cleavage awaits the crystal 
structure of Pol I. 
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Figure 32 | Biochemical properties 
of Pol I A12.2ΔC. (A) Electrophoretic 
mobility shift assay (EMSA). (B) 
Elongation activity of the Pol I variant 
A12.2ΔC. 
 
Since A12.2 is required for transcription termination (Prescott et al., 2004), Pol I 
cleavage activity may be involved in a termination-coupled reaction. RNA 
cleavage could be required for rRNA 3’-terminal trimming, a Pol I-associated 
RNA processing event that intimately follows termination and involves cleavage 
of ten nucleotides from the pre-rRNA 3’-end (Kuhn and Grummt, 1989). 
Consistently, Pol II can form a binary complex with RNA and cleave RNA from 
the 3’-end in the presence of TFIIS (Johnson and Chamberlin, 1994). 
It is very likely that the intrinsic cleavage activity of Pol I also enables rRNA 
proofreading, to increase transcriptional fidelity. Indeed, repetition of our 
cleavage assay with a scaffold that contains only a single mismatch at the RNA 
3’-end, mimicking the situation after a misincorporation event, induced efficient 
RNA cleavage (not shown). For Pol III, the intrinsic cleavage activity was 
recently shown to enable proofreading in a manner dependent on the A12.2 
homolog C11 (Alic et al., 2007), which is required for the intrinsic cleavage 
activity of Pol III (Chedin et al., 1998; Landrieux et al., 2006). 
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II.11 | Conclusions 
 
 
Figure 33 | Hybrid structure and functional architecture of Pol I. The EM envelope is shown 
as a blue line, the Pol I core ribbon model in grey with Rpb9 (A12.2) highlighted in orange, and 
the A14/43 crystal structure in red/blue. The window shows a cut-away view of the active center 
containing a modeled DNA-RNA hybrid. Red dashes indicate the RNA 3’-end extruded into the 
pore. 
 
In this thesis a reproducible large-scale purification protocol for RNA 
polymerase I from S. cerevisiae was developed. Many crucial steps were 
completed successfully on the way to an atomic resolution X-ray structure of 
this huge, multi-subunit complex: Crystals were obtained by microseeding, 
diffraction to < 4 Å could be recorded of heavy atom soaked crystals and 
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complete data to 4.8 Å could be processed. However, the enormously complex 
non-crystallographic symmetry in the asymmetric unit of Pol I impeded structure 
solution.  
Single-particle cryo-electron microscopy provided a way out of this dilemma: 
The detailed functional architecture of Pol I could be elucidated by a 
combination of structural biology techniques and structure-based functional 
analysis (Fig. 33). Comparison with the Pol II system revealed Pol I-specific 
features that match the unique nature of rRNA transcription. First, the distinct 
structure of the Pol I upstream face allows for specific initiation factor 
interactions and recruitment of Pol I to the rRNA promoter. Second, the built-in 
elongation-stimulatory Pol I-specific subcomplex A49/34.5 can explain the 
efficient and processive nature of rRNA transcription during cell growth. Third, 
the intrinsic RNA cleavage activity apparently enables rRNA 3’-trimming and 
proofreading, to prevent formation of erroneous rRNAs and catalytically 
deficient ribosomes. Finally, our results will help to unravel structural and 
functional relationships between the three eukaryotic transcription machineries, 
and form the basis for a detailed structure-function analysis of rRNA 
transcription and processing. 
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III.1 | Purification of RNA Polymerase I from S. cerevisiae 
 
Buffers and media used during purification: 
 
YPD medium (for small fermenter) 
300g peptone 
300g glucose 
225g yeast extract 
add 15 L with desalted water 
pH adjusted to 6.9 with 1M NaOH 
50 µg/ml ampicilin1 
10 µg/ml tetracycline1 
 
100x Protease Inhibitors (PI) 
1mM phenylmethylsulphonyl fluoride (PMSF) 
1mM benzamidine 
200µM pepstatin 
60µM leupeptin 
dissolved in 100% EtOH 
Freezing buffer 
150 mM HEPES, pH 7.8 
60 mM MgCl2 
30% (v/v) glycerol 
5 mM DTT1 
1x PI1 
 
Dilution buffer 
100 mM HEPES, pH 7.8 
20 mM MgCl2 
400 mM (NH4)SO4 
5 mM DTT1 
1x PI1 
 
2x Dialysis buffer 
100 mM KOAc 
40 mM HEPES, pH 7.8 
20 mM MgCl2 
10% (v/v) glycerol 
10 mM mercaptoethanol1 
1 mM benzamidine1 
1 mM PMSF1 
 
Res/W1 buffer 
1.5 M KOAc 
20 mM HEPES, pH 7.8 
1 mM MgCl2 
10% (v/v) glycerol 
10 mM mercaptoethanol1 
0.5x PI1 
 
W2 buffer 
300 mM KOAc 
20 mM HEPES, pH 7.8 
1 mM MgCl2 
10% (v/v) glycerol 
10 mM mercaptoethanol1 
 
E100 buffer 
300 mM KOAc 
20mM HEPES, pH 7.8 
1 mM MgCl2 
100 mM imidazole 
10% (v/v) glycerol 
10 mM mercaptoethanol1 
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MonoQ buffer A 
20 mM HEPES, pH 7.8 
1 mM MgCl2 
10% (v/v) glycerol 
5 mM DTT1 
MonoQ buffer B 
2 M KOAc 
20 mM HEPES, pH 7.8 
1mM MgCl2 
10% (v/v) glycerol 
5 mM DTT1 
 
Superose 6 buffer A 
60 mM (NH4)2SO4 
5 mM HEPES, pH 7.8 
1 mM MgCl2 
10 µM ZnCl2 
5 mM DTT1 
 
 
1 added prior to usage  
 
The complete 14-subunit Pol I was isolated from a modified version of the 
S. cerevisiae strain GPY2 (ade2-101, trp1-Δ63, ura3-52, his3-Δ200, lys2-801, 
leu2::RPA43), carrying a pAS22 plasmid coding for a HA- and hexahistidine-
tagged version of A43. A 20 L fermenter (Infors ISF) was inoculated to a starting 
OD600 of 0.15-0.3 with cells cultivated in shaking flasks. Fermentation was 
carried out in YPD medium at 30 °C, using a stirrer speed of 650 rpm and an air 
flow of 8 L/min. Growth was allowed to proceed for approx. 8-9 hours until the 
culture reached an OD600 of 1.5. This pre-culture was used to inoculate a 200 L 
fermenter (Infors ABEC) with a starting OD600 of 0.15. Cells were grown over 
night at 30 °C until they reached an OD600 of 5-9 (approx. 18h, Fig. 6, Chapter 
II.1). Harvesting cells was achieved by flow-throw centrifugation at 20,000 rpm 
(Padberg Z4IG), yielding 1.7-2.8 kg of yeast pellet. Cells were re-suspended in 
500 ml of freezing buffer per kg of cells and stored at  -80 °C after shock-
freezing in 225 mL batches in liquid nitrogen. 
For each ‘standard’ Pol I purification two 225 mL cell batches were carefully 
thawed in warm water. Ammonium sulfate was added to a final concentration of 
400 mM, DTT and protease inhibitors were added to final concentrations of 
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5 mM and 1 x respectively. To prevent foam formation every BeadBeaterTM 
(Biospec Inc.) was filled up to prevent an airspace, using dilution buffer. Yeast 
cells were lysed using 200 mL glass beads per BeadBeater. Lysis was carried 
out in repetitive cycles of 30 s bead-beating followed by 1 min of cooling. During 
this 1 h procedure the lysate was cooled using a salt-water mixture. Thereafter, 
glass beads were separated by filtration prior to clearing the lysate by 
centrifugation (30 min, 8000 x g, Sorvall SLA-1500). The whole cell extract was 
ultra-centrifuged for 90 min at 30,000 x g (Beckman SW-28). After aspiring the 
top fat layer, the clear supernatant was dialyzed over night at 4 °C against        
1 x dialysis buffer. The dialyzed extract was centrifuged for 1 h at 18,500 x g 
(Beckman Ti-45), the pellet re-suspended in app. 50 mL Res/W1-buffer and 
incubated with 8 mL Nickel-NTA Agarose (Qiagen) for 4 h at 4 °C on a turning 
wheel. The resin was packed into 2 gravity flow nickel columns and washed 
with 5 column volumes (CV) of Res/W1 buffer and 5 CV of W2-buffer, and 
eluted using 50 mL E100 buffer. For anion-chromatography, a Mono-Q column 
(MonoQ 10/100 GL, GE Healthcare) was equilibrated with 15% MonoQ buffer B 
and eluted with MonoQ buffer B, using a multi-step gradient (Fig. 7, Chapter 
II.1), resulting in an elution peak for Pol I at 1100 mM KOAc (Fig. 8, Chapter 
II.1). Peak fractions were pooled (approx. 10 mL)  and diluted to a final KOAc-
concentration of 200 mM. A cation-exchange column (MonoS 5/50 GL, GE 
Healthcare) was used for the next purification stage, using the MonoQ buffers A 
and B and applying a gradient from 200mM KOAc to 2M KOAc (Fig. 9, Chapter 
II.1). Pure Pol I eluted at a salt concentration of 490 mM KOAc (Fig. 10A, 
Chapter II.1). To remove remaining glycerol and to check for monodispersity, 
the protein was finally purified on a Superose 6 HR10/30 size-exclusion column 
(GE Healthcare) in Superose 6 buffer A (Fig. 11, Chapter II.1).  
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III.2 | Purification of Pol I variants 
 
Additional buffers for purifying Pol I variants: 
 
Urea dissociation buffer 
2 M urea 
50 mM ammonium sulfate 
1 mM magnesium chloride 
20 mM HEPES, pH 7.8 
10% (v/v) glycerol 
5 mM DTT1 
 
MonoQ buffer C 
50 mM ammonium sulfate 
20 mM HEPES, pH 7.8 
1mM MgCl2 
10% (v/v) glycerol 
5 mM DTT1 
MonoQ buffer D 
1 M ammonium sulfate 
20 mM HEPES, pH 7.8 
1mM MgCl2 
10% (v/v) glycerol 
5 mM DTT1 
Superose 6 buffer B 
100 mM ammonium sulfate 
20 mM HEPES, pH 7.8 
5% (v/v) glycerol 
1 mM MgCl2 
10 µM ZnCl2 
5 mM DTT1 
 
1added prior to usage  
 
Pol I lacking the A49/34.5 heterodimer (Pol I ΔA49/34.5) was prepared by 
controlled urea dissociation of A49/34.5 from complete Pol I. Pol I-containing 
fractions after cation-exchange chromatography (Chapters II.1 and III.1) were 
dialyzed over night against a urea dissociation buffer. A49/34.5 was separated 
from Pol I ΔA49/34.5 by subsequent anion-exchange chromatography, applying 
a linear gradient from 50 mM to 1 M ammonium sulfate, using MonoQ buffers C 
and D. Pol I ΔA49/34.5 was further purified by size-exclusion chromatography 
(Superose 6 HR10/300, GE Healthcare) using Superose 6 buffer B (Fig. 26A, 
Chapter II.9). For further biochemical use (Chapters II.9 and II.10) pooled 
fractions were concentrated to 0.5 mg/mL.  
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The Pol I variant lacking the C-terminal residues 79-125 of A12.2 (Pol I 
A12.2ΔC) was fermented in synthetic dextrose complete (SDC) medium lacking 
histidine and purified exactly as described for the complete enzyme (Chapter 
III.1), omitting the final gel filtration step. Pol I A12.2ΔC was concentrated to 0.5 
mg/mL in Superose 6 buffer B. The yield for this Pol I variant was incredibly low, 
not more than 50 µg protein could be obtained from 200 g of cell pellet. 
 
 
III.3 | Crystallization of Pol I 
 
III.3.1 | Crystallization by vapor diffusion 
 
Pol I purified as described in Chapter III.1, was concentrated to 5.5 mg/mL in 
Membra-Spin Mini columns (membraPure, Bodenheim, Germany). UV 
absorption at λ = 280 nm was measured and protein concentration was 
determined assuming an absorption coefficient of 0.656 for a 1 mg/mL protein 
solution (derived from ProtParam on www.expasy.ch). To allow for slow 
concentration of the sample centrifuge speed was reduced to 6,500 rpm at       
4 °C. Before crystallization the protein was centrifuged at 14,000 rpm for 30 min 
at 4 °C to remove dust and aggregated particles. 
Crystallization was always carried out using vapor diffusion. For hanging drops 
EasyXtal Tools (Nextal/Qiagen) were used, for sitting drops Linbro plates 
(Hampton Research). Drops were set using 500 µL reservoir solution and 1 µL 
protein + 1 µL reservoir drops. Protein was added prior to adding reservoir 
solution. The reservoir contained in all cases fresh reducing agent, either 5 mM 
DTT or 3 mM Tris(2-carboxyethyl)phosphine (TCEP). 
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III.3.2 | Streak-seeding 
 
Crystals of suitable size for measuring X-ray diffraction data could only be 
obtained using streak-seeding (Bergfors, 2003). Cat whiskers were ‘stolen’ from 
Micio (Michela’s cat), Lintelo (Katrin’s cat) and Mia (Anette’s cat). Vapor 
diffusion setups were allowed to equilibrate for 3-3.5 h prior to streak-seeding. 
Source drops, from which seeds were derived, were prepared for seeding by 
adding 10 µL of reservoir solution (fresh reducing agent was added prior to 
dilution). Seeds were collected by streaking several times with the cat whisker 
through the diluted source drop. Every streak-seeding trial was performed for at 
least 6 identical drops, diluting the seeds consecutively. Drops were closed 
immediately after having streaked through them (Fig. 13, Chapter II.2). 
 
 
III.3.3 | Crystal harvesting and cryo-protection 
 
Crystals grew to maximum dimensions of 500µm x 60µm x 10µm. For crystal 
manipulation and freezing tools from Hampton Research (Aliso Viejo, USA) 
were used. 5 µL of reservoir solution was added to the drop containing the 
crystals. For cryo-protection crystals were transferred to spot plates containing 
100 µL of the crystallization condition + 6% PEG-400 (3 mM TCEP was freshly 
added). Crystals were allowed to equilibrate for approx. ½ h before increasing 
the concentration of cryo-protectant stepwise to 12, 18 and finally 22% PEG-
400. Solutions were exchanged rather than crystals transferred to the new cryo-
solution. The final 22% step was repeated to ensure full exchange of cryo-
solutions. 
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III.3.4 | Heavy atom derivatization and crystal freezing 
 
A grain of a W18 cluster (NH4)6(P2W18O62)⋅14H2O) (Dawson, 1953; Thygesen et 
al., 1996) was added to the final cryo-solution containing 22% PEG-400. 
Crystals were slowly cooled down to 8 °C using a styrofoam box, and kept at 
this temperature for app. 44 h. Crystals were plunged into liquid nitrogen and 
stored at liquid nitrogen temperature until data collection. For details on different 
heavy atom derivatization techniques see Table 2, Chapter II.3. Crystals were 
harvested using 20 µm CrystalCap HT equipment from Hampton Research 
(loop size 0.1 – 0.4 mm, sample holder length 22 mm). 
 
 
III.4 | Data collection 
 
During the course of improving crystal size and diffraction quality, many 
different ways of collecting data on Pol I crystals were tried. The following 
paragraph illustrates the approach for some of the best crystals collected. 
All diffraction data were recorded at the beamlines X06SA and X10SA at the 
Swiss Light Source (SLS) in Villigen, Switzerland, using a Mar225 detector (Mar 
Research). To verify the W18 cluster in the crystal, an X-ray absorption scan 
was performed at the L-III edge of tungstate (10.21 keV or 1.21 Å) before 
measurement of reflexions (Fig. 15A, Chapter II.4). The main difficulty was the 
extreme sensitivity of the crystals when exposed to X-rays. Therefore the beam 
flux was kept constant at 1 x 1012 photons/s to enable comparison of diffraction 
quality between crystals. The beam was focused on the detector rather than on 
the crystal for reducing radiation damage. Crystals were all of monoclinic space 
group C2, requiring at least a 90° rotation for recording all possible anomalous 
pairs. Strategies to minimize X-ray exposure for collecting complete data were 
simulated using MOSFLM (Leslie, 2006). In most cases, an exposure time of    
1 s per 0.5° oscillation was used; one image of the direct beam was recorded 
for every detector–crystal distance to allow best possible indexing. Even though 
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the unit cell dimensions were huge, no overlapping reflections were predicted 
by MOSFLM, an effect due to the limited resolution. However, even after 
following all these preventative measures, several translations on a single 
crystal were necessary to record a full dataset, introducing many problems 
concerning data integration and scaling. 
 
 
III.5 | Data processing 
 
Data were processed with HKL2000 (Otwinowski and Minor, 1997), not using 
the graphical interface but DENZO and SCALEPACK scripts (Chapter IV.1). 
SCALEPACK had to be used with its derivative SCALEPACKRIBO to account 
for the enormous number of measured reflections. During integration most 
difficulties arose from radiation-damage induced cell parameter changes, which 
made refinement of these parameters very difficult. Scaling often suffered from 
high mosaicity of > 0.7° and many different translations. Suitable images for 
scaling were determined by monitoring the average I/σ(I) per frame and the 
batch-wise R-factor in the output log-file of SCALEPACK. The model for 
systematic error was stepwise adjusted including all rejected reflections in each 
cycle until convergence. Data quality criteria of I/σ(I) above 2 and an Rmerge of 
< 35% were applied before subsequent attempts at phasing (Fig. 16C, Chapter 
II.4). 
Self-rotation functions were calculated using POLARRFN from the CCP4 
package (CCP4, 1994) and GLRF (Tong and Rossmann, 1990). Stereographic 
projections were calculated for κ = 52° and κ = 180°. See Chapter IV.2 for 
details. 
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III.6 | Attempts on structure solution 
 
III.6.1 | Experimental phasing 
 
For locating the W18 and Ta6Br122+ clusters in anomalous difference Patterson 
maps the program SOLVE was used (Terwilliger and Berendzen, 1999), see 
sample scripts in Chapter IV.3. SHELXD (Schneider and Sheldrick, 2002), 
which uses direct methods for solving sub-structures, and its graphical interface 
HKL2MAP (Pape and Schneider, 2004) were also tried with various input 
settings (resolution range, Patterson seeding, number of sites). Unfortunately, 
none of the various trials produced unambiguous heavy atom sites. 
 
 
III.6.2 | Molecular replacement 
 
For molecular replacement various models based on the Pol II structure 
(Armache et al., 2003) were constructed: Model 1 comprised Rpb1, 2, 3 and 11 
of the Pol II structure, including deletions according to hand-made structure-
based alignments (Chapter IV.7); the identical subunits Rpb5, 6, 8, 10 and 12 
were kept, but Rpb4, 7 and 9 were excluded due to limited sequence 
conservation. Model 2 additionally included the tip domain of Rpb7 (amino acids 
1-82) and the N-terminus of Rpb9 (amino acids 2-39), which could possibly 
have enhanced the molecular replacement signal due to Rpb7 protruding from 
of the core polymerase. Model 3 was a poly-alanine model of Model 2 (but 
maintained any glycine residues). Model 4 was also identical to Model 2, 
however, it was based on the TFIIS-bound RNA polymerase II structure 
(Kettenberger et al., 2004), in which large parts of Pol II are slightly shifted 
against each other.  
All these models were used for running PHASER (McCoy et al., 2005; Read, 
2001; Storoni et al., 2004). However, even after extensively examining all 
possible variations in the rotation and translation functions, fixing solutions or 
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changing parameters like the search radius, the similarity score or the included 
reflections, no plausible solutions could be obtained, the main problem being 
the presence of 7 molecules per asymmetric unit (Fig. 17, Chapter II.5). To 
exploit the high NCS symmetry of the apparent 7-fold ring the locked cross-
rotation function of GLRF (Tong and Rossmann, 1990) and MOLREP (Vagin 
and Teplyakov, 1997) were used, but this did not lead to improved signals. 
Nevertheless, MOLREP resulted in some rotation solutions that did obey the 7-
fold symmetry, but unfortunately, none of these 7-fold related solutions were 
successfully solved by the following translation function (Fig. 18A, Chapter II.5).  
Apart from crystallographic models the cryo-EM structure of Pol I 
(Chapter II.6) was used for molecular replacement. For that purpose the EM 
map had first to be converted into CCP4-format using SPIDER (Frank et al., 
1996). The SPIDER volume was interpolated to 1 Å/pixel using the command 
IP. The resulting volume was padded into a 300 Å x 300 Å x 300 Å unit cell 
using PD. After determination of the center of gravity (command CG) the 
molecule was shifted to this center (command SH) and finally the map was 
converted to CCP4-format using CP TO CCP4 in 32-bit mode. This resulting 
map was used as a search model in MOLREP, with the self-rotation information 
calculated previously. The table of rotation solutions showed for the first time 
clusters of 7 solutions in one plane (Figure 18B, Chapter II.5), and gave us 
confidence that this was representative of the 7-fold NCS. The low- and high-
resolution cut-offs were set to 12 Å and 80 Å respectively, corresponding to the 
limits of both the crystallographic and EM data (for detailed script see Chapter 
IV.4). 
However, the translation function could not be solved using these rotational 
solutions.  
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III.7 | Cryo-electron microscopy of Pol I 
 
III.7.1 | Negative stain 
 
For EM data collection, Pol I was concentrated to 5.5 mg/mL, as for 
crystallographic purposes (Chapter III.3.1). For determining the optimal protein 
concentration for cryo-EM, negative stain images were recorded with a Philips 
CM100 transmission electron microscope operated at 100 kV and a nominal 
magnification of 28,500 (defocus ranging from -300 nm to -500 nm). The 
sample was stained using 2% uranyl acetate. An optimal protein concentration 
of 0.1 mg/mL for cryo-EM could be established by assessing particle density 
visually (Fig. 20A, Chapter II.6). 
 
 
III.7.2 | Preparation of grids 
 
A thin carbon layer was vapor-deposited onto a mica layer (Plano GmbH, 
Wetzlar, Germany) using a Bench Top Turbo IV Coating System (Denton 
Vacuum LLC, Morestown, USA) using a vacuum of 5-10 x 10-6 Torr. The ultra-
thin carbon layer was floated onto water before applying it to carbon holey grids 
(Quantifoil). For making the carbon surface hydrophilic, grids were ionized in a 
plasma cleaner chamber (Model PDC002, Harrick, UK). 3.5 µL of sample were 
applied to the grid and subsequently vitrified in liquid ethane using the half-
automated VitrobotTM system (FEI, Eindhoven, Netherlands) under controlled 
conditions (6 °C, 100% humidity, 45 s incubation time, 7.5 s blotting) 
(Wagenknecht et al., 1988). Grids were transferred into liquid nitrogen for long-
term storage. 
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III.7.3 | Cryo-EM data collection 
 
Data were collected using a Tecnai Polara F30 field emission gun microscope 
operated at 300 kV and a magnification of 39,000 (Max-Planck Institute of 
Molecular Genetics, Berlin). Frozen grids were transferred into the specimen 
holder of the microscope under liquid nitrogen conditions. Meshes were 
screened by hand to identify suitable ones for data collection and sample 
images recorded on a 4k x 4k CCD camera (Fig. 20B, Chapter II.6). 
Micrographs were only recorded in regions of thin carbon with a low dose of 20 
electrons/Å2 and an exposure time of 1 s. Micrographs were developed and 
scanned on a Heidelberg drum scanner with a pixel size of 1.23 Å (5334 dpi) on 
the object scale. Micrographs were saved as high resolution TIFF-files. 
 
 
III.7.4 | Image processing for 14-subunit Pol I 
 
All data were processed using the SPIDER software package (Frank et al., 
1996). For all TIFF images the contrast transfer function and defocus values 
were determined using CTFFIND (p_ctffind.rib, (Mindell and Grigorieff, 2003)). 
Power spectra were visually inspected in Web (part of the SPIDER package). 
59 micrographs (out of 84 recorded) that displayed very little drift and 
astigmatism were further considered and were 3-fold decimated to a pixel size 
of 3.69 Å/pixel (sig_decimate.rib) with a box size of 60 pixels. Particles were 
picked automatically with SIGNATURE (sig_pick.rib) (Chen and Grigorieff, 
2007), using 5 projections of the 12-subunit Pol II structure (Armache et al., 
2005) as template. Bad particles were excluded from the dataset after visual 
inspection in Web (p_window.rib, p_dcs_flt.rib, p_copygood.rib). Selected 
micrographs were assigned to 29 defocus groups having similar defocus values 
(see Chapter IV.5). 
In the first alignment step 31,600 particles from 15 micrographs were aligned to 
projections of the reference volume (p_alidef.rib). As a reference, the Pol II 
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structure, filtered at 20 Å resolution, was modified by deleting the clamp and 
foot domains of Rpb1 and Rpb4/7 except for the Rpb7 tip. Depending on the 
defocus value of each defocus group, the reference was distorted with the 
corresponding CTF function in angular increments of 15°, which resulted in 83 
projections. Allowed shifts of particles in x and y directions were first kept as 
large as possible and successively tightened during refinement. The alignment 
procedure resulted in the best fitting projections (according to cross-correlation) 
for each particle and the shifts and rotational changes needed to match each 
projection.  
Particles were backprojected using the parameters gained from the alignment 
(p_trans.rib, p_spinnem2.rib, p_rotate.rib, p_angles.rib, bp32f_n.rib). To 
determine the resolution of the reconstruction, the dataset was randomly split 
into two equal subsets, both were backprojected and CTF corrected. The 
resolution was then determined based on Fourier shell correlation (FSC), using 
a cut-off value of 0.5 (Fig. 20D, Chapter II.6). 
In the first round of refinement particles were aligned to the volume resulting 
from the first backprojection. Further refinement required creation of so-called 
‘stack’ files containing aligned particles and transformation files containing shifts 
and rotational parameters to fit the reference projection. Particles were 
iteratively aligned to new references created by the aligned particles in the 
preceding round. Initially, all possible reference projections were offered to each 
particle. Later, reference projections that are compared become more and more 
restricted to a defined angular and translational range. In our case, density for 
the clamp and foot reappeared during early refinement, confirming the absence 
of reference bias. To account for the many different clamp conformations, 
particles were sorted into two subsets according to two different clamp 
conformations (Penczek et al., 2006). For that purpose two different volumes 
were offered to the refinement algorithm. For Pol I, we offered as volume 2 the 
initial reference containing the clamp in a position similar to Pol II. Sorting 
resulted in 19,130 particles with a closed clamp conformation (volume 1, class I) 
and 12,546 particles with an open clamp conformation (volume 2, class II) with 
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3D reconstructions at a resolution of approx. 17 Å (Fig. 20C, Chapter II.6). To 
be able to reach higher resolution, the pixel size was decreased to 1.84 Å/pixel 
at this stage. Addition of more particles from the remaining 44 micrographs and 
further sorting against human Pol II (Kostek et al., 2006) resulted in 46,056 
particles and led to a reconstruction at a resolution of 11.9 Å (0.5 FSC). During 
the last refinement rounds (in total 151), a better algorithm (BP RP), based on 
real space backprojection, was applied, which resulted in higher resolution 
reconstructions. Higher frequencies were corrected by multiplying the 3D-
volume in Fourier space using an exponential function, similar to a 
crystallographic b-factor. 
 
 
III.8 | Cryo-EM data processing for 12-subunit Pol I ΔA49/34.5 
 
For cryo-EM structure determination of Pol I ΔA49/34.5, data processing was 
carried out as for the complete Pol I, and was again bias-free. 20,668 particles 
of high defocus values (> 3 µm, Chapter IV.6) from 13 micrographs were 
aligned with SPIDER (Frank et al., 1996) using the same reference as for the 
complete Pol I (Chapter III.7). Only spurious density fragments were observed 
in the region assigned to the two dissociated subunits. Sorting for the A49/34.5 
density was carried out until convergence (Penczek et al., 2006). Sorting 
revealed once more the enormous flexibility of the clamp since, apart from the 
missing density for A49/34.5, there were also different clamp positions 
observable. The remaining 11,226 particles were backprojected using the 
BP32F algorithm, resulting in a volume with 25 Å resolution (Fig. 26B, Chapter 
II.9). 
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III.9 | Modeling of the Pol I core 
 
The Rpb4/7 sub-complex was removed from the complete Pol II structure and 
the five common subunits were retained in the model. For the Pol II subunits 
Rpb1, Rpb2, Rpb3, Rpb9, and Rpb11, sequence alignments with their Pol I 
homologues were obtained with CLUSTAL W (Thompson et al., 1994) and were 
used for initial homology modeling. Side chains in these four Pol II subunits 
were kept when identical in the Pol I homologues, and otherwise replaced by 
the most common rotamer of the counterpart residues, using the rotamer library 
of the program O (Jones et al., 1991). Regions in Pol II subunits that were 
apparently not present in Pol I subunits were deleted. The resulting ten-subunit 
model was inspected ‘residue by residue’, and showed meaningful internal non-
polar contacts and salt bridges in most regions. Several regions however 
showed steric clashes or disallowed contacts, indicating misalignment of the 
corresponding sequence stretches. Manual realignment of these weakly 
conserved stretches led to a model with good internal packing. The procedure 
was repeated several times until convergence (Fig. 23, Chapter II.7 and 
Chapter IV.7). 
 
 
III.10 | Structure prediction of A49/34.5 
 
The sequences of the two Pol I specific subunits A49 and A34.5 were sent to 
the HHpred server for remote protein homology detection and structure 
prediction(Soding et al., 2005) using default settings. For the highest scoring hit, 
HHpred predicted a structural similarity of the A49 N-terminal residues 52-102 
to the N-terminal residues 99-150 of the large subunit of the human Pol II-
associated factor TFIIF, RAP74 (P-value = 0.0023). For A34.5 the hit with the 
third highest score showed a similarity between the A34.5 residues 50-65 and 
residues 15-30 of the small subunit of TFIIF, RAP30 (P-value = 0.0003). 
Inspection of the predicted secondary structure elements in the apparent 
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regions of distant homology in A49 revealed a similar arrangement of strands 
as in the crystal structure of the dimerization module of RAP74/RAP30 (Gaiser 
et al., 2000) (PDB 1F3U) except that the two strands β4 and β5 are apparently 
lacking in A49, and no secondary structure corresponding to the strands β6 and 
β7 of RAP30 was predicted in A34.5. Strikingly, the few residues that are 
conserved between A49 and RAP74 and between A34.5 and RAP30 are 
generally part of the hydrophobic core of the heterodimer interface. Mutations of 
these residues led to strongly impaired co-purification of the A49/34.5 
heterodimer (Fig. 28B-D, Chapter II.9). 
 
 
III.11 | Purification of recombinant A49/34.5 
 
Buffers used during purification: 
 
A49-A 
300 mM NaCl 
50 mM Tris, pH 7.5 
10 mM β-mercaptoethanol1 
1x PI1 
 
A49-highsalt 
1 M NaCl 
50 mM Tris pH 7.5  
10 mM β-mercaptoethanol1 
A49-dilution 
50 mM Tris pH 7.5 
10 mM β-mercaptoethanol1 
 
A49-B 
100 mM NaCl 
50 mM Tris pH 7.5 
5 mM DTT1 
 
1 added prior to usage  
 
The genes for A49 and A34.5 were amplified from yeast genomic DNA by PCR 
and were cloned into vector pET28b (Novagen), resulting in a C-terminal 
hexahistidine tag on A49 and introducing a second ribosomal binding site for 
bicistronic expression. The two subunits were co-expressed for 18 hours at 18 
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°C in E. coli BL21 (DE3) RIL cells (Stratagene) in 4 L of LB medium (Sambrook 
and Russel, 2001). Cells were harvested by centrifugation, resuspended in 100 
mL buffer A49-A and lysed by sonication. After centrifugation the supernatant 
was loaded onto a 3 mL Ni-NTA column (Qiagen) equilibrated with buffer A49-
A. The column was washed stepwise with 15 mL of buffer A49-A, 15 mL of A49-
highsalt buffer and 15 mL of buffer A49-A containing 30 mM imidazole. The 
A49/34.5 heterodimer was eluted with buffer A49-A containing 100 mM 
imidazole. Eluted fractions were diluted three-fold with A49-dilution buffer, and 
further purified by cation exchange chromatography (MonoS 10/100 GL, GE 
Healthcare). The MonoS column was equilibrated with buffer A49-B and 
proteins were eluted with a linear gradient of 18 CV from 100 mM to 1 M NaCl. 
A49/34.5 eluted at 280 mM NaCl. The sample was applied to a Superose 12 
HR 10/300 gel filtration column (GE Healthcare) equilibrated with buffer A49-B 
(Fig. 28A, Chapter II.9). Pooled peak fractions were concentrated to 1 mg/mL 
and glycerol was added to a final concentration of 10% (v/v). Protein aliquots 
were flash-frozen in liquid nitrogen and stored at -80 °C.  
 
 
III.12 | Yeast genetics 
 
III.12.1 | 6-azauracil phenotyping of GPY2 ΔRPA34 
 
To disrupt the gene coding for A34.5, His5+ from S. pombe (complementing 
HIS3 from S. cerevisiae) was amplified from pFA6a-His3MX6 (Longtine et al., 
1998) using PCR (Primer A: 5’AGTGAGCAGCTAGGATTCAATAAACGGGA 
TTAACAAAAAATTGATAGATCTGTTTAGCTTGCCTC-3’; Primer B: 5’CACA 
TTTTTATCTT ATGTTACACACAGTTATACGCACATACGCATGAATTCGAGCT 
CGTTTAAAC-3’). S. cerevisiae strain GPY2 was transformed by the LiAc-
method (Kaiser et al., 2004), positive clones were selected using –His plates 
and verified by colony PCR. For testing elongation activity, GPY2 and 
GPY2ΔRPA34, both harboring the pRS316 plasmid, were spotted onto SDC 
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plates lacking uracil and containing 60 µg/mL 6-azauracil. Growth was 
monitored after 2-3 days at 30 °C.  
 
 
III.12.2 | Cloning and fermentation of GPY2 RPA12ΔC 
 
To generate a C-terminal deletion in A12.2 (ΔG79-N125), A12.2 was deleted in 
GPY2 essentially like described in Chapter III.12.1, using KanMX instead of 
His5+ as genetic marker. The resulting strain GPY2 (rpa12::KanMX) was 
transformed with a plasmid (pRS313-RPA12(aa1-78)) coding for the N-terminus 
and the ‘potential’ linker region in A12.2 (residues 1-78). Transformed yeast 
cells (rpa12::KanMX(pRS313-RPA12(aa1-78)) were selected on SDC plates –
His and screened by colony PCR. A positive clone (Pol I A12.2ΔC) was grown 
to a maximum OD600 of ~ 3 in SDC medium lacking histidine (Kaiser et al., 
2004) using a 20 L fermenter (Infors ISF) and following the same procedure as 
described in Chapter III.1. A total of 240 g of yeast pellet could be harvested 
from 50 L of yeast culture. 
 
 
III.13 | In vitro RNA assays 
 
III.13.1 | RNA extension assays using a minimal scaffold 
  
4 pmol Pol I, Pol I ΔA49/34.5, or Pol I A12.2ΔC were incubated for 30 min at   
20 °C with 2 pmol of a pre-annealed minimal nucleic acid scaffold (template 
DNA: 3’-GCTCAGCCTGGTCCGCATGTGTCAGTC-5’; non-template DNA: 5’-C 
ACACAGTCAG-3’; RNA: 5’-FAM-UGCAUAAAGACCAGGC-3’).  
For complementing Pol I ΔA49/34.5, a fivefold molar excess of recombinant 
A49/34.5 was incubated with Pol I ΔA49/34.5  for 10 min at 20 °C, prior to 
forming the polymerase-scaffold complex. For RNA elongation, complexes were 
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incubated in the presence of 1 mM NTPs at 28 °C for 20 min in transcription 
buffer (60 mM ammonium sulfate, 20 mM HEPES pH 7.6, 8 mM magnesium 
sulfate, 10mM zinc chloride, 10% glycerol, 10 mM DTT). Reactions were 
stopped by addition of an equal volume (12 µL) 2x loading buffer (8 M urea,      
2 x TBE) and incubation for 5 min at 95 °C. FAM-labeled RNA extension 
products were separated by denaturing gel electrophoresis (0.5 pmol RNA per 
lane, 0.4 mm 15-20% polyacrylamide gels containing 8 M urea, 50-55 °C) and 
visualized with a Typhoon 9400 phosphoimager (GE Healthcare). FAM was 
excited with blue light at λ = 488 nm and fluorescent signal was recorded with a 
520 BP 40 band-pass filter. 
 
 
III.13.2 | RNA extension assays using a complementary bubble 
 
For RNA extension assays with a complementary bubble (Kireeva et al., 2000), 
6 pmol Pol I or Pol I ΔA49/34.5 were incubated for 15 min at 20 °C with 3 pmol 
of a pre-annealed RNA-template DNA scaffold (template DNA: 3’-
TGCGCACCACGCTTACTGGTCCGTTCGCCTGTCCTCGACCA-5’; RNA: 5’-
FAM-UGCAUUUCGACCAGGC-3’). For complementing Pol I ΔA49/34.5, a 
fivefold molar excess of recombinant A49/34.5 (30 pmol) was incubated with 
Pol I ΔA49/34.5  for 15 min at 20 °C, prior to forming the polymerase-scaffold 
complex. Annealing to the RNA-template DNA scaffold was followed by 
incubation with a fivefold molar excess of non-template DNA (15 pmol; 5’-
TTTTTACGCGTGGTGCGAATGACCAGGCAAGCGGACAGGAGCTGGT-3’) for 
15 min at 25 °C. Formed complexes were incubated in the presence of 1 mM 
NTPs at 28 °C for 1 and 5 min in transcription buffer. Reactions were stopped 
and analyzed by gel electrophoresis as described in Chapter III.13.1. 
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III.13.3  | RNA cleavage assays 
 
Complexes of complete Pol I, Pol I ΔA49/34.5, or Pol I A12.2ΔC were formed in 
transcription buffer with a nucleic acid scaffold that comprised an RNA with a 6-
FAM fluorescent label at its 5’-end and a three-nucleotide non-complementary 
overhang at its 3’-end (template DNA: 3’-TTACTGGTCCTTTTTCATGAACTC 
GA-5’; non-template DNA: 5’-TAAGTACTTGAGCT-3’; RNA: 5’-FAM-UGCAUU 
UCGACCAGGACGU-3’, overhanging nucleotides underlined). For RNA 
cleavage reactions, samples were incubated in transcription buffer up to 30 min 
at 28 °C. RNA species were revealed by electrophoresis and fluorescence 
detection as described in Chapter III.13.1. 
 
 
III.13.4  | Electrophoretic mobility shift assay (EMSA) 
 
10 pmol of the scaffold used for cleavage assays (Chapter III.13.3) was 
incubated with 10 or 15 pmol of Pol I, Pol I ΔA49/34.5 or Pol I A12.2ΔC for 30 
min at 20 °C. Protein-bound scaffold was separated from unbound RNA on a 
native 6% TBE gel at 4 °C (0.5 x TBE as running buffer, 90V, 1 - 1.5 h). RNA 
was stained with 1:10,000 SYBR gold and visualized with a Typhoon scanner 
(Fig. 32A, Chapter II.10). SYBR gold was excited with blue light at λ = 488 nm, 
fluorescence was detected with a 555 BP 20 band-pass filter. 
 
 
III.14 | Figure preparation 
 
Figures were prepared with CHIMERA (Pettersen et al., 2004) and PYMOL 
(DeLano Scientific). 
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IV.1 | DENZO and SCALEPACK scripts 
 
Data integration with DENZO (auto.inp): 
 
[crystal rotx   37.199 roty  167.206 rotz   -8.634] 
[crossfire y  0.001 x -0.007 xy -0.003] 
title                  'ck290' 
distance               550  [You can get the distance and wavelength] 
wavelength             1.02290 [from the ASCII header of any image 
file ] 
 
[x beam y beam from the measured direct beam position at 550 mm] 
x beam                108.0  
y beam                109.5 
     
air absorption length  2800  [good value for Se energies] 
format  ccd unsupported-m225 
goniostat aligment 0 0 
goniostat single axis 
monochromator          0.99 
       
space group            c2   [ Use P1 if unknown ] 
unit cell  614.24 302.58 252.83  90.00  97.51  90.00 
mosaicity              0.8  [ an estimate at this point ] 
weak level             5.0  [adjust value to eliminate bad peaks in               
indexing] 
box                    2.4 2.4 
spot                   elliptical 0.35 0.35 0.0 
background             elliptical 0.5 0.5 0.0 
overlap                spot 
profile fitting radius 20.0 
 
raw data file          
'/xtal/cr_lise2/kuhn/crystals/ck290/ck290_1_###.img' [ <== edit ] 
film output file       'ck290_###.x'                   [ <== edit ] 
 
oscillation            start -10 range 0.5  
[start is phi value at image 001][range is phi width per image ] 
sector                 1 to 1   [ number of image, see ### in name 
template ] 
 
[fit x beam y beam cell crystal rotx roty rotz] 
print statistics 
 
longest vector         900 [ somewhat greater than longest expected 
cell axis ] 
 
peak search file       peaks.file 
write predictions 
 
resolution limits      80.0 4.5   [ <== edit ] 
go 
write predictions  
go  
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Crystal parameter refinement during integration with DENZO (ref.dat): 
 
start refinement 
 
resolution limits 80.0 7.0 
fix all 
refine partiality 
fit crystal rotx roty rotz  
go go go 
fit x beam y beam   
go go go  
fit cell 
go go go  
fit crossfire x y xy 
go go go  
fit cassette rotx roty 
go go go go go go 
fit distance  
go go go 
 
resolution limits 80.0 4.5 
fix all 
refine partiality 
fit crystal rotx roty rotz 
go go go 
fit x beam y beam 
go go go 
fit crossfire x y xy 
go go go 
fit cassette rotx roty 
go go go go 
fit distance 
go go  
 
print profiles 3 3 
list 
calculate go 
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Data scaling with SCALEPACK (scale.inp): 
 
[Output] 
output file 'ck290.sca' 
[Pretty standard stuff] 
format denzo_ip 
number of zones 10 
estimated error 
0.09   0.08   0.07   0.06   0.05 
0.05   0.05   0.05   0.05   0.05 
error scale factor 1.2 
rejection probability 0.00005 
write rejection file 0.9 
scale restrain 0.02 
b restrain 1.0 
anomalous 
[no merge original index] [<== edit for getting unmerged data, i.e. 
for running SOLVE] 
ignore overloads              
@reject.1 
 
[Crystal data] 
space group C2 
resolution 80 4.5 
reference film 1 
 
postrefine 10 [10 cycles of postrefinemet] 
fit crystal a* 1 to 722 
fit crystal b* 1 to 722 
fit crystal c* 1 to 722 
fit crystal beta* 1 to 722 
fit film rotx 1 to 722 
fit film roty 1 to 722 
[fit batch rotz 5 to 50] 
fit crystal mosaicity 1 to 60 81 to 140 173 to 334 361 to 510 551 to 
634 635 to 722 
[Mosaicity was fitted for each translation in this case] 
 
add partials 1 to 60 81 to 140 173 to 334 361 to 510 551 to 634 635 to 
722 
 
[hkl matrix  0  0  1   0 -1  0   1  0  0] [<== edit for re-indexing] 
 
sector 1 to 60 
FILE 1 'ck290_###.x' 
 
sector 81 to 140 
FILE 81 'ck290_###.x' 
 
sector 173 to 334 
FILE 173 'ck290_###.x' 
 
sector 361 to 510 
FILE 361 'ck290_###.x' 
 
sector 551 to 722 
FILE 551 'ck290_###.x' 
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IV.2 | Self-rotation function scripts 
 
Self-rotation calculation with POLARRFN (poalrrfn.com): 
 
polarrfn HKLIN ../crank/ck209_FI.mtz \ 
MAPOUT ck209_polarrfn.map \ 
PLOT ck209_polarrfn.plt <<EOF 
title selfrot 
SELF 70.0 
RESOLUTION 70 6.0 
LABIN FILE 1 F=FP SIGF=SIGFP 
CRYSTAL FILE 1 
CRYSTAL ORTH 1 
LIMITS 0 180 2 0 180 2 0 180 2 
MAP  
PLOT 30 5  
!contour level to start - contour intervals 
FIND 30 50 OUTPUT selfrotpeaks.list  
!threshold for peaks - peaks to find   
NOPRINT 
EOF 
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Self-rotation calculation with GLRF (srf.inp): 
 
title Pol1 ordinary self rotation function 
! 
print ck209_srf_polar.prt 
! 
polar xyk 
euler zyz 
orthog axabz 
! 
!locsymmetry 1 0 0 7 polar 
!locsymmetry 0 1 0 2 polar 
!locexpand true 
! 
acell 619.346 305.423 251.200 90.000 97.488 90.000 
asymmetry c2 
aobsfile ../ck209_noanom_noheader.sca 
acutoff 1.0 1.0 0.0 
aformat 3I4, 2F8.0 
apower 1 
origin true 
! 
!cutoff 0.25 
! 
resolution 70.0 6.2 
radius 60.0 
boxsize 3 3 3 
geval 2 
! 
self true 
cross false 
fast true 
norm false 
! 
sangle polar 
!rcut 1 20 
slimit 1 0 180 2  
slimit 2 0 180 2 
slimit 3 0 180 2 
oangle polar xyk 
! 
!mapfile ck209_srf_polar.map 
peak 3 50 
pkfit 10 1.5 
! 
cntfile ck209_srf_polar.ps 
cntl 400 1000 20 
! 
stop 
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IV.3 | SOLVE scripts 
 
W18 localization using Patterson methods (solve_SAD_W18.com): 
 
#COMPUTER ENVIRONMENT 
# 
setenv SYMINFO /xray/programs/solve/solve-2.11/lib/syminfo.lib 
setenv CCP4_OPEN UNKNOWN 
setenv SOLVETMPDIR /var/tmp 
setenv SYMOP /xray/programs/solve/solve-2.11/lib/symop.lib 
setenv SYMINFO /xray/programs/solve/solve-2.11/lib/syminfo.lib 
# 
unlimit 
# 
/xray/programs/solve/solve-2.11/bin/solve_extra_huge <<EOD 
 
#CRYSTAL INFORMATION 
resolution 70 9.0 
cell 613.56   302.42   248.73  90.000  97.473  90.000 
symfile /xray/programs/solve/solve-2.11/lib/c2.sym 
 
#INPUT DATA   ! input for external phase information, here from MR 
#LABIN FP=FP SIGFP=SIGFP FPH1=FPH1 SIGFPH1=SIGFPH1 
#LABIN DPH1=DPH1 SIGDPH1=SIGDPH1 
#HKLIN ../molrep_input.mtz 
#PHASES_LABIN FC=FC PHIC=PHIC FOM=FOM 
#PHASES_MTZ ../molrep.mtz 
 
readformatted        ! readformatted/readdenzo/readtrek 
         readccp4_unmerged 
unmerged             ! premerged/unmerged 
read_intensities     ! read_intensities/read_amplitudes 
fixscattfactors      ! fixscattfactors/refscattfactors 
rawnativefile        /home2/kuhn/crystals/ck209/xds/ck209_mod.ahkl 
 
#PSEUDO-MIR INPUT FOR W18 
derivative 1 
label SAD data for wclu 
 
newatomtype wclu  
clus_aval 2903 5109.4 -1197.1 -5254.3 
clus_bval 509.3 -37.8 849.4 108.5 
clus_cval 184 30 1.2 
 
clus_fp_aval 0.185886 0.453782 -0.10632 -0.466651 
clus_fp_bval 509.3 -37.8 849.4 108.5 
clus_fp_cval 184 30 1.2 
 
clus_fpp_aval 0.185886 0.453782 -0.10632 -0.466651 
clus_fpp_bval 509.3 -37.8 849.4 108.5 
clus_fpp_cval 184 30 1.2 
 
atom wclu 
fprimv -6.753 
fprprv 25 
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#xyz  0.2161  0.0000  0.3823    ! site from visual inspection of  
                       patterson map 
 
rawderivfile /home2/kuhn/crystals/ck209/xds/ck209_mod.ahkl 
 
anoonly 
nsolsite 7                      ! number of sites per derivative 
SCALE_NATIVE                    ! scale the native dataset 
SCALE_MIR                       ! scale the derivs to the native 
ANALYZE_MIR                     ! analyze this MIR data and set up 
              for SOLVE 
#addsolve                       ! look for more sites then refine and 
    phase 
SOLVE 
EOD 
 
 
 
 
 
Ta6Br122+ localization using Patterson methods (solve_SAD_TaBr.com): 
 
#COMPUTER ENVIRONMENT 
# 
setenv SYMINFO /usr/local/lib/solve/syminfo.lib 
setenv CCP4_OPEN UNKNOWN 
setenv SOLVETMPDIR /var/tmp 
setenv SYMOP /usr/local/lib/solve/symop.lib 
setenv SYMINFO /usr/local/lib/solve/syminfo.lib 
# 
unlimit 
# 
/usr/local/xtal/solve-2.10/bin/solve_giant<<EOD 
 
#CRYSTAL INFORMATION 
resolution 50 7.5 
cell 615.047 305.472 251.809  90.000  97.044  90.000 
symfile /usr/local/lib/solve/c2.sym 
 
#INPUT DATA 
readdenzo            ! readformatted/readdenzo/readtrek 
                       readccp4_unmerged 
unmerged             ! premerged/ unmerged 
read_intensities     ! read_intensities/read_amplitudes 
fixscattfactors      ! fixscattfactors/refscattfactors 
rawnativefile        /home2/kuhn/crystals/ck209/xds/ck209_mod.sca 
 
#PSEUDO-MIR INPUT FOR TA6BR12 CLUSTER 
derivative 1 
label SAD data for TaBr 
 
newatomtype tabr 
clus_aval 795.88 -757.81 908.87 127.86 
clus_bval 301.24 460.86 301.37 -24.026 
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clus_cval -237.92 1.0 4.0 
 
clus_fp_aval 5.565 -5.299 6.356 0.894 
clus_fp_bval 301.24 460.86 301.37 -24.026 
clus_fp_cval -1.516 1.0 4.0 
 
clus_fpp_aval 5.565 -5.299 6.356 0.894 
clus_fpp_bval 301.24 460.86 301.37 -24.026 
clus_fpp_cval -1.516 1.0 4.0 
 
atom tabr 
fprimv -17.398 
fprprv 15.780 
 
rawderivfile /home2/kuhn/crystals/ck209/xds/ck209_mod.sca 
 
#SAD 
anoonly 
nsolsite_deriv 7        ! 7 atoms max 
#addsolve 
SCALE_NATIVE 
SCALE_MIR 
ANALYZE_MIR 
SOLVE 
EOD 
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IV.4 | MOLREP script 
 
Molecular replacement using an EM map (molrep_rotation.com): 
 
# -------------------------------- 
molrep <<stop 
# -------------------------------- 
# 
_DOC Y 
_SCORE Y 
# 
_FILE_F input/ck290_dec06.mtz 
# 
_F  F 
_SIGF  SIGF 
_END     <--- end of MTZ block 
# 
_FILE_M input/val067f_300.map 
_DSCALEM 1 
_INVERM N 
_DRAD 60 
_ORIGIN 0.5,0.5,0.5   
# 
_RESMIN 80 
_RESMAX 12 
# 
_FUN R 
_NP 20  
_FILE_T  rotations_val067_300.tab 
_NCSM 1 
_ANISO C 
_RAD 70 
_SIM 0.7 
_COMPL 0.14 
_NMON 7 
_NPT 20 
#self-rotation information 
_LOCK Y 
_NSRF 6 
_FILE_TSR input/7fold.list 
_CHI 52 
_END 
stop 
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IV.5 | Initial cryo-EM processing for 14-subunit Pol I 
 
Image number Particles / image Defocus value (µm) Defocus group 
47 1483 0,83 1 
56 991 0,99 1 
68 1316 1,03 2 
79 1385 1,12 3 
45 1484 1,12 3 
48 1278 1,12 3 
71 1264 1,16 4 
63 1376 1,17 4 
78 1367 1,18 5 
38 1236 1,20 5 
76 1460 1,20 5 
80 1116 1,21 5 
33 1001 1,26 6 
70 2181 1,28 6 
28 1163 1,29 7 
84 1480 1,29 7 
73 1429 1,31 7 
34 1056 1,31 7 
82 939 1,35 8 
75 2329 1,36 8 
42 2243 1,37 8 
7 2164 1,37 9 
37 1859 1,37 9 
29 1011 1,38 9 
43 1489 1,40 9 
11 1818 1,42 10 
58 1705 1,42 10 
54 1139 1,43 10 
18 2154 1,45 11 
50 1844 1,47 11 
35 1370 1,52 12 
64 1332 1,53 12 
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59 1474 1,57 13 
40 1811 1,58 13 
61 1245 1,61 14 
49 1500 1,63 15 
44 1722 1,64 15 
69 1321 1,71 16 
53 1308 1,72 16 
52 1266 1,72 16 
16 2379 1,74 17 
57 1011 1,83 18 
4 1978 1,83 18 
74 1436 1,86 19 
25 2363 1,89 20 
9 1327 1,91 20 
14 2279 1,94 21 
30 1325 2,00 22 
24 2262 2,02 22 
62 1541 2,09 23 
3 1927 2,16 24 
65 1944 2,19 25 
15 2243 2,27 26 
8 2195 2,37 27 
55 1230 2,39 27 
60 1957 2,41 27 
6 2061 2,42 27 
19 2400 2,48 28 
12 2126 2,52 29 
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IV.6 | Initial cryo-EM processing for Pol I ΔA49/34.5 
 
Image number Particles/image Defocus value (µm) Defocus group 
34 1495.0 3,02 1 
46 1564.0 3,03 1 
50 1582.0 3,07 2 
22 1631.0 3,11 2 
17 1641.0 3,31 3 
33 1650.0 3,31 3 
10 1709.0 3,35 3 
43 1528.0 3,36 3 
9 1663.0 3,44 4 
49 1625.0 3,46 4 
32 1552.0 3,60 5 
18 1530.0 3,61 6 
29 1552.0 3,61 6 
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IV.7 | Sequence alignments 
 
Sequence alignments of Pol I subunits with their respective homologs in Pol II. 
Alignments were generated with CLUSTAL W (Thompson et al., 1994) and 
were then edited based on structural modeling. Regions of conserved fold are 
underlined. Additional regions of conserved fold likely exist but cannot be 
predicted with certainty. 
 
A190-Rpb1 edited by hand according to 3D structure, EM density and  
secondary structure prediction 
 
 
A190      ---MDISKPVGSEITSVDFGILTAKEIRNLSAKQITNPTVLDNLG-HPVSGGLYDLALGA 56 
Rpb1      MVGQQYSSAPLRTVKEVQFGLFSPEEVRAISVAKIRFPETMDETQTRAKIGGLNDPRLGS 60 
                *         * **     * *  *   *  *   *        *** *  **  
 
A190      FLRNL-CSTCGLDEKFCPGHQGHIELPVPCYNPLFFNQLYIYLRASCLFCHHFRLKSVE- 114 
Rpb1      IDRNLKCQTCQEGMNECPGHFGHIDLAKPVFHVGFIAKIKKVCECVCMHCGKLLLDEHNE 120 
            *** * **      **** *** *  *     *           *  *    *      
 
A190      VHRYACKLRLLQYGLIDESYKLDEITLGSLNSSMYTDDEAIEDNEDEMDGEGSKQSKDISS 175 
Rpb1      LMRQALAIKDSKKRFAAIWTLCKTKMVCETDVPSEDDP----------------------- 158 
            * * *                             *    
 
A190      TLLNELKSKRSEYVDMAIAKALSDGRTTERGSFTATVNDERKKLVHEFHKKLLSRGKCDN 235 
Rpb1      ------------------------------------------------------------  
                                                                            
 
A190      CGMFSPKFRKDGFTKIFETALNEKQITNNRVKGFIRQDMIKKQKQAKKLDGSNEASANDE 295 
Rpb1      --------------------------------------------TQLVSRGGCGNTQPTI 174 
                                                             *       
 
A190      ESFDVGRNPTTRPKTGSTYILSTEVKNILDTVFRKEQCVLQYVFHSRPNLSRKLVKADSF 355 
Rpb1      RKDGLKLVGSWKKDRATGDADEPELRVLSTEEILNIFKHISVKDFTSLGFNEVFSRPEWM 234 
                                 *                                         
 
A190      FMDVLVVPPTRFRLPSKLGEEVHENSQNQLLSKVLTTSLLIRDLNDDLSKLQKDKVSLED 415 
Rpb1      ILTCLPVPPPPVRPSISFNESQRG---EDDLTFKLADILKANISLETLEHNGAP------ 285 
              * ***   *      *          *   *   *        *           
 
A190      RRVIFSRLMNAFVTIQNDVNAFIDSTKAQG-RTSGKVPIPGVKQALEKKEGLFRKHMMGKR 475 
Rpb1      --HHAIEEAESLLQFHVATYMDNDIAGQPQALQKSGRPVKSIRARLKGKEGRIRGNLMGKR 344 
                                 *             *       *  ***  *   **** 
 
A190      VNYAARSVISPDPNIETNEIGVPPVFAVKLTYPEPVTAYNIAELRQAVINGPDKWPGATQ 535 
Rpb1      VDFSARTVISGDPNLELDQVGVPKSIAKTLTYPEVVTPYNIDRLTQLVRNGPNEHPGAKY 404 
          *   ** *** *** *    ***   *  ***** ** ***  * * * ***   ***   
 
A190      IQNEDGSLVSLIGMSVEQRKALANQLLTPSSNVSTHTLNKKVYRHIKNRDVVLMNRQPTL 595 
Rpb1      VIRDSGDRIDLR--------------YSKRAGDIQLQYGWKVERHIMDNDPVLFNRQPSL 450 
               *    *                             ** ***   * ** **** * 
 
A190      HKASMMGHKVRVLPNEKTLRLHYANTGAYNADFDGDEMNMHFPQNENARAEALNLANTDS 655 
Rpb1      HKMSMMAHRVKVIPYS-TFRLNLSVTSPYNADFDGDEMNLHVPQSEETRAELSQLCAVPL 509 
          ** *** * * * *   * **    *  *********** * ** *  ***   *      
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A190      QYLTPTSGSPVRGLIQDHISAGVWLTSKDSFFTREQYQQYIYGCIRPEDGHTTRSKIVTL 715 
Rpb1      QIVSPQSNKPCMGIVQDTLCGIRKLTLRDTFIELDQVLNMLYWVPDWDG--------VIP 561 
          *   * *  *  *  **       **  * *    *     *               *   
 
A190      PPTIFKPYPLWTGKQIITTVLLNVTPPDMPGINLISKNKIKNEYWGKGSLENEVLFKDGA 775 
Rpb1      TPAIIKPKPLWSGKQILSVAIP----------NGIHLQRFDEGTTLLSPKDNGMLIIDGQ 611 
           * * ** *** ****                * *                *  *  **  
 
A190      LLCGILDKSQYGASKYGIVHSLHEVYGPEVAAKVLSVLGRLFTNYITATAFTCGMDDLRL 835 
Rpb1      IIFGVVEKKTVGSSNGGLIHVVTREKGPQVCAKLFGNIQKVVNFWLLHNGFSTGIGDT-- 669 
             *   *   * *  *  *      ** * **                 *  *  *    
 
A190      TAEGNKWRTDILKTSVDTGREAAAEVTNLDKDTPADDPELLKRLQEILRDNNKSGILDAV 895 
Rpb1      -----IADGPTMREITETIAEAKKKVLDVTKEAQAN-----------LLTAKHGMTLRES 713 
                           *  **   *    *   *            *        *    
 
A190      TSSKVNAITSQVVSKCVPDGTMKKFPCNSMQAMALSGAKGSNVNVSQIMCLLGQQALEGR 955 
Rpb1      FEDNVVRFLNEARDKAGRLAEVNLKDLNNVKQMVMAGSKGSFINIAQMSACVGQQSVEGK 773 
              *         *            *    *   * ***  *  *     ***  **  
 
A190      RVPVMVSGKTLPSFKPYETDAMAGGYVKGRFYSGIKPQEYYFHCMAGREGLIDTAVKTSR 1015 
Rpb1      RIAFGFVDRTLPHFSKDDYSPESKGFVENSYLRGLTPQEFFFHAMGGREGLIDTAVKTAE 833 
          *        *** *          * *      *  ***  ** * ************   
 
A190      SGYLQRCLTKQLEGVHVSYDNSIRDADGTLVQFMYGGDAIDITKESHMTQFEFCLDNYYA 1075 
Rpb1      TGYIQRRLVKALEDIMVHYDNTTRNSLGNVIQFIYGEDGMDAAHIEKQ-SLDTIGGSDAA 892 
           ** ** * * **   * ***  *   *   ** ** *  *                  * 
 
A190      LLKKY------------------------------------------------------- 1080 
Rpb1      FEKRYRVDLLNTDHTLDPSLLESGSEILGDLKLQVLLDEEYKQLVKDRKFLREVFVDGEA 952 
            * *                   *     *     *    * *    *         *  
 
A190      -------NPSALIEHLDVESALKYSKKTLKYRKKHSKEPHYKQSVKYDPVLAKYNPAKYL 1133 
Rpb1      NWPLPVNIRRIIQNAQQTFHIDHTKPSDLTIKDIVLGVKDLQENLLVLRGKNEIIQNAQR 1012 
                                                                                                
 
A190      GSVSENFQDKLESFLDKNSKLFKSSDGVNEKKFRALMQLKYMRSLINPGEAVGIIASQSV 1193 
Rpb1      DAVTLFCCLLRSRLATRRVLQEYRLTKQAFDWVLSNIEAQFLRSVVHPGEMVGVLAAQSI 1072 
            *                                       **   *** **  * **  
 
A190      GEPSTQMTLNTFHFAGHGAANVTLGIPRLREIVMTASAAIKTPQMTLPIWN--DVSDEQA 1251 
Rpb1      GEPATQMTLNTFHFAGVASKKVTSGVPRLKEILN-VAKNMKTPSLTVYLEPGHAADQEQA 1131 
          *** ************     ** * *** **        ***  *           *** 
 
A190      DTFCKSISKVLLSEVIDKVIVTETTGTSNTAGGNAARSYVIHMRFFDNNEYSEEYDVSKE 1311 
Rpb1      KLIRSAIEHTTLKSVTIASEIYYDPDPRSTVIPEDEEIIQLHFSLLDEEAEQSFDQQSPW 1191 
                *    *  *              *           *    *          *   
 
A190      ELQNVISNQFIHLLEAAIVKEIKKQKRTTGPDIGVAVPRLQTDVANSSSNSKRLEEDNDE 1371 
Rpb1      LLRLELDRAAMNDKDLTMGQVGERIKQTFKNDLFVIWSEDNDEKLIIRCRVVRPKSLDAE 1251 
           *                       * *   *  *                 *      * 
 
A190      EQSHKKTKQAVSYDEPDEDEIETMREAEKSSDEEGIDSDKESDSDSEDEDVDMNEQINKS 1422 
Rpb1      TEAEEDHMLKKIENTMLENITLR------------------------------------- 1274 
                           *         
 
A190      IVEANNNMNKVQRDRQSAIISHHRFITKYNFDDESGKWCEFKLELAADTEKLLMVNIVEE 1491 
Rpb1      --------------------------------------------------------GVEN 1278 
                                                                   ** 
 
A190      ICRKSIIRQIPHIDRCVHPEPENGKRVLVTEGVNFQAMWDQEAFIDVDGITSNDVAAVLK 1551  
Rpb1      IERVVMMKYDRKVPSPTGEYVKEPEWVLETDGVNLSEVMTVPG-IDPTRIYTNSFIDIME 1337 
          * *                       ** * ***          **   *  *  
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A190      TYGVEAARNTIVNEINNVFSRYAISVSFRHLDLIADMMTRQGTYLAFNRQGMETS-TSSF 1610 
Rpb1      VLGIEAGRAALYKEVYNVIASDGSYVNYRHMALLVDVMTTQGGLTSVTRHGFNRSNTGAL 1398 
            * ** *     *  **       *  **  *  * ** **      * *   * * 
 
A190      MKMSYETTCQFLTKAVLDNEREQLDSPSARIVVGKLNNVGTGSFDVLAKVPNAA-- 1664 
Rpb1      MRCSFEETVEILFEAGASAELDDCRGVSENVILGQMAPIGTGAFDVMIDEESLVKY 1453 ->CTD 
          *  * * *   *  *    *       *     *     *** *** 
 
 
 
 
 
A135-Rpb2 edited by hand according to 3D structure, EM density and  
secondary structure prediction 
 
 
A135      MSKVIKPPGQARTADFRTLERESRFINPPKDKSAFPLLQEAVQPHIGSFNALTEGPDGGL 60 
Rpb2      MSDLANSE-KYYDEDPYGFEDESAPITAEDSWAVISAFFREKGLVSQQLDSFNQFVDYTL 59                           
          **            *    * **  *                              *  * 
 
A135      LNLGVKDIGEKVIFDGKPLNSEDEISNSGYLGNKLSVSVEQVSIAKPMSNDGVSSAVERK 120 
Rpb2      QDIICEDS--TLILEQLAQHTTE----SDNISRKYEISFGKIYVTKPMVNE--SDGVTHA 111 
                *     *              *     *   *       *** *   *  *    
 
A135      VYPSESRQRLTSYRGKLLLKLKWSVNN-----GEENLFEVRD-------------CGGLP 162 
Rpb2      LYPQEARLRNLTYSSGLFVDVKKRTYEAIDVPGRELKYELIAEESEDDSESGKVFIGRLP 171 
           ** * * *   *   *    *          * *   *                 * ** 
 
A135      VMLQSNRCHLNKMSPYELVQHKEESDEIGGYFIVNGIEKLIRMLIVQRRNHPMAIIRPSF 222 
Rpb2      IMLRSKNCYLSEATESDLYKLKECPFDMGGYFIINGSEKVLIAQERSAGNIVQVFKKAAP 231 
           ** *  * *       *   **     ***** ** **          *         
 
A135      ANRGASYSHYGIQIRSVRPDQTSQTNVLHYLNDGQVTFRFSWRKNEYLVPVVMILKALCH 282 
Rpb2      SPISHVAEIRSALEKGSRFISTLQVKLYGREGSSARTIKATLPYIKQDIPIVIIFRALGI 291 
                           *   * *            *            * * *  **   
 
A135      TSDREIFDGIIGNDVKDSFLTDRLELLLRGFKKRYPHLQNRTQVLQYLGDKFRVVFQASP 342 
Rpb2      IPDGEILEHIC-YDVNDWQMLEMLKPCVEDG----FVIQDRETALDFIGR--RGTALGIK 344 
            * **   *   ** *      *              * *   *   *   *        
 
A135      DQSDLEVGQEVLDRIVLVHLGKDG--SQDKFRMLLFMIRKLYSLVAGECSPDNPDATQHQ 400 
Rpb2      KEKRIQYAKDILQKEFLPHITQLEGFESRKAFFLGYMINRLLLCALDRKDQDDRDHFGKK 404 
                     *    * *          *   *  **  *          *  *      
 
A135      EVLLGGFLYGMILKEKIDEYLQNIIAQVRMDINRGMAINFKDKRYMSRVLMRVNENIGSK 460 
Rpb2      RLDLAGPLLAQLFKTLFKKLTKDIFRYMQRTVEEAHDFNMK--------LAINAKTITSG 456 
             * * *     *         *              * *        *      * *  
 
A135      MQYFLSTGNLVSQSGLDLQQVSGYTVVAEKINFYRFISHFRMVHRGSFFAQLKTTTVRKL 520 
Rpb2      LKYALATGNWGEQK-KAMSSRAGVSQVLNRYTYSSTLSHLRRTN-TPIGRDGKLAKPRQL 514 
            * * ***   *         *   *          ** *           *    * * 
 
A135      LPESWGFLCPVHTPDGSPCGLLNHFAHKCRISTQQSDVSRIPSILYSLGVAPASHTFAAG 580 
Rpb2      HNTHWGLVCPAETPEGQACGLVKNLSLMSCISVG-TDPMPIITFLSEWGMEPLEDYVPHQ 573 
              **  **  ** *  ***         **    *   *   *   *  *         
 
A135      -PSLCCVQIDGKIIGWVSHEQGKIIADTLRYWKVEGKTPGLPIDLEIG----YVPPSTRGQ- 636 
Rpb2      SPDATRVFVNGVWHGV--HRNPARLMETLRTLRRKGDINPEVSMIRDIREKELKIFTDAGRV 633 
                *   *   *   *        ***     *                       * 
 
A135      YPGLYLFGG---------HSRMLRPVRYLPLDK-----------------------EDIV 662 
Rpb2      YRPLFIVEDDESLGHKELKVRKGHIAKLMATEYQDIEGGFEDVEEYTWSSLLNEGLVEYI 693 
          *  *                *                                           
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A135      GPFEQVYMNIAVTPQEIQ-----------------------NNVHTHVEFTPTNILSILA 701 
Rpb2      DAEEEESILIAMQPEDLEPAEANEENDLDVDPAKRIRVSHHATTFTHCEIHPSMILGVAA 753 
             *     **  *                               ** *  *  **   * 
 
A135      NLTPFSDFNQSPRNMYQCQMGKQTMGTPGVALCHRSDNKLYRLQTGQTPIVKANLYDDYG 761 
Rpb2      SIIPFPDHNQSPRNTYQSAMGKQAMGVFLTNYNVRMDTMANILYYPQKPLGTTRAMEYLK 813 
             ** * ****** **  **** **        * *     *   * *            
 
A135      MDNFPNGFNAVVAVISYTGYDMDDAMIINKSADERGFGYGTMYKTEK-VDLALNRNRGDP 820 
Rpb2      FRELPAGQNAIVAIACYSGYNQEDSMIMNQSSIDRGLFRSLFFRSYMDQEKKYGMSITET 873 
              * * ** **   * **   * ** * *   **    
 
A135      ITQHFGFGNDEWPKEWLEKLDEDGLPYIGTYVEEGDPICAYFDDT-------LNKTKIKT 873 
Rpb2      FEKPQRTNTLRMKHGTYDKLDDDGLIAPGVRVSGEDVIIGKTTPISPDEEELGQRTAYHS 933 
                            *** ***   *  *   * *                 *    
 
A135      YHSSEPAYIEEVNLIGDESNKFQE---LQTVSIKYRIRRTPQIGDKFSSRHGQKGVCSRK 930 
Rpb2      KRDASTPLRSTENGIVDQVLVTTNQDGLKFVKVRVRTTKIPQIGDKFASRHGQKGTIGIT 993 
                      * * *          *  *    *    ******* ******* 
 
A135      WPTIDMPFSETGIQPDIIINPHAFPSRMTIGMFVESLAGKAGALHGIAQDSTPWIFNEDD 990 
Rpb2      YRREDMPFTAEGIVPDLIINPHAIPSRMTVAHLIECLLSKVAALSGNEGDASPFT----D 1049 
              ****   ** ** ****** *****     * *  *  ** *   *  *      * 
 
A135      TPADYFGEQLAKAGYNYHGNEPMYSGATGEELRADIYVGVVYYQRLRHMVNDKFQVRSTG 1050 
Rpb2      ITVEGISKLLREHGYQSRGFEVMYNGHTGKKLMAQIFFGPTYYQRLRHMVDDKIHARARG 1109 
                   *   **   * * ** * **  * * *  *  ********* **   *  * 
 
A135      PVNSLTMQPVKGRKRHGGIRVGEMERDALIGHGTSFLLQDRLLNSSDYTQASVCRECGSI 1110 
Rpb2      PMQVLTRQPVEGRSRDGGLRFGEMERDCMIAHGAASFLKERLMEASDAFRVHICGICGLM 1169 
          *   ** *** ** * ** * ******  * **    *  **   **      *  **   
 
A135      LTTQQSVPRIGSISTVCCRRCSMRFEDAKKLLTKSEDGEKIFIDDSQIWEDGQGNKFVGG 1170 
Rpb2      TVIAKLN-----HNQFECKGCDN------------------------------------K 1188 
                           *  *                                        
 
A135      NETTTVAIPFVLKYLDSELSAMGIRLRYNVEPK--- 1203 
Rpb2      IDIYQIHIPYAAKLLFQELMAMNITPRLYTDRSRDF 1224 
                 **   * *  ** ** *  *    
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AC40-Rpb3 edited by hand according to 3D structure, EM density and  
secondary structure prediction 
 
 
AC40      MSNIVGIEYNRVTNTTSTDFPGFSKDAENEWNVEKFKKDFEVNISSLDAREANFDLINID 60 
Rpb3      ----------------------------------MSEEGPQVKIREASKDNVDFILSNVD 26 
                                                   * *         * * * * 
 
AC40      TSIANAFRRIMISEVPSVAAEYVYFFNNTSVIQDEVLAHRIGLVPLK-VDPDMLTWVDSN 119 
Rpb3      LAMANSLRRVMIAEIPTLAIDSVEVETNTTVLADEFIAHRLGLIPLQSMDIEQLEYSRDC 86 
             **  ** ** * *  *   *    ** *  **  *** ** **   *   *       
 
AC40      LPDDEKFTDENTIVLSLNVKCTRNPDAPKGSTDPKELYNNAHVYARDLKFEPQGRQSTTF 179 
Rpb3      FCED--HCDKCSVVLTLQAFGESE--------------STTNVYSKDLVIVSNLMGRNIG 130 
             *    *    ** *                         **  **             
 
AC40      ADCPVVPADPDILLAKLRPGQEISLKAHCILGIGGDHAKFSPVSTASYRLLPQINILQPI 239 
Rpb3      HPIIQDKEGNGVLICKLRKGQELKLTCVAKKGIAKEHAKWGPAAAIEFEYDPWNKLKH-- 188 
                      *  *** ***  *      **   ***  *         *       
 
AC40      KGESARRFQKCFPPGVIGIDEGSDEAYVKDARKDTVSREVLRYEEFADK---VKLGRVRN 296 
Rpb3      ----------------------TDYWYEQDSAKEWPQSKNCEYEDPPNEGDPFDYKAQAD 226 
                                 *  *  *  *         **  
 
AC40      HFIFNVESAGAMTPEEIFFKSVRILKNKAEYLKNCPITQ--------------------- 335 
Rpb3      TFYMNVESVGSIPVDQVVVRGIDTLQKKVASIL-LALTQMDQDKVNFASGDNNTASNMLG 282 
           *  **** *              *  *         **   
 
AC40      --------------------------------- 356 
Rpb3      SNEDVMMTGAEQDPYSNASQMGNTGSGGYDNAW 318 
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AC19-Rpb11 edited by hand according to 3D structure, EM density and  
secondary structure prediction 
 
 
AC19      MTEDIEQKKTATEVTPQEPKHIQEEEEQDVDMTGDEEQEEEPDREKIKLLTQATSEDGTS 60 
Rpb11     ------------------------------MNAPDRFELFLLGEGESKLKIDPDTKAPNA 30 
                                            *            **     
 
AC19       ASFQIVEEDHTLGNALRYVIMKNPDVEFCGYSIPHPSENLLNIRIQTYGETTAVDALQKG 120 
Rpb11      VVITFEKEDHTLGNLIRAELLNDRKVLFAAYKVEHPFFARFKLRIQTTEGYDPKDALKNA 90 
                  *******  *        * *  *   **       ****       ***    
 
AC19       LKDLMDLCDVVESKFTEKIKSM-------- 142 
Rpb11      CNSIINKLGALKTNFETEWNLQTLAADDAF 120 
                         *  
 
 
 
 
 
A12.2-Rpb9 edited by hand according to 3D structure, EM density and 
secondary structure prediction 
 
 
A12.2      MSVVGSLIFCLDCGDLLENPNAVLG---SNVECSQCKAIYPKSQFSNLKVVTTTADDAFPSSLR 61 
Rpb9       ---MTTFRFCRDCNNMLY-PREDKENNRLLFECRTCSYVEEAGSPLVYRHELITNIGETAGVVQ 60 
                   ** **   *  *      *    **  *                 * 
 
A12.2      AKKSVVKTSLKKNELKDGATIKEKCPQCGNEEMNYHTLQLRSADEGATVFYTCTSCGYKFRTNN 125 
Rpb9       DIGSDPTLPR----------SDRECPKCHSRENVFFQSQQRRKDTSMVLFFVCLSCSHIFTSDQ 114 
              *                    ** *   *      * *  *     *  * **   *    
 
A12.2      -------- 125 
Rpb9       KNKRTQFS 122  
 
 
 
 
A12.2 C-terminus      -----RAKKSVVKTSLKKNE---LKDGATIKEKCPQCGNEEMNYHTLQLR 32 
TFIIS 3rd domain      PAPLKQKIEEIAKQNLYNAQGATIERSVTDRFTCGKCKEKKVSYYQLQTR 50 
                                  *  *            *    *  *      *  ** *  
 
A12.2 C-terminus      SADEGATVFYTCTSCGYKFRTNN 65 
TFIIS 3rd domain      SADEPLTTFCTCEACGNRWKFS- 72 
                      ****  * * **  ** 
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